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Abstract 
 
Background: Currently, there is no known patient reported outcome (PRO) 
instrument being used in clinical practice for the home parenteral nutrition (HPN) 
population. To address this gap, the Home Parenteral Nutrition-Patient Reported 
Outcome Questionnaire (HPN-PROQ) was developed for use during medical 
appointments or homecare visits. The purpose of this research is to provide evidence 
that the items and scales of the HPN-PROQ possess content validity, a crucial step in 
the process of questionnaire development. 
Subjects: Qualitative sample included 32 HPN patients and quantitative sample 
included 13 expert home care clinicians (physicians, dietitian, pharmacists, registered 
nurses and patient advocates.) 
Methods: In Phase I, cognitive interviews (CI) were conducted to evaluate HPN 
patients’ understanding of the instructions, items, and response scales on a draft HPN-
PROQ. The draft HPN-PROQ was revised based on results of CIs. In Phase II, a 
revised draft was sent to expert clinicians to complete the Content Validity Index 
(CVI). Any item achieving a I-CVI kappa score ≤ 0.783 was removed.  The Scale-
CVI-Average (S-CVI/AVG) was calculated following a second round of CVI by a 
reduced expert panel.  
Results: The final HPN-PROQ contains thirty-four items with an I-CVI score ≥ 0.783. 
The overall S-CVI/AVG score of the HPN-PROQ was 0.961. 
Conclusion: This study provides evidence that the HPN-PROQ has acceptable 
content-validity and after future validation procedures, may be appropriate as a new 
tool for fostering dialogue between HPN patients and their clinicians.
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Clinical Relevancy Statement 
 
 The Home Parenteral Nutrition-Patient Reported Outcomes Questionnaire 
(HPN-PROQ) is a novel tool which is designed to foster dialog between HPN patients 
and providers around quality of life constructs. This study provides support for the 
content validity of the HPN-PROQ.  
Introduction 
 
Background 
 
 Home parenteral nutrition (HPN) is a complex therapy involving the 
intravenous infusion of nutrients and fluids to individuals who have intestinal failure 
or dysfunction.1 It is estimated that 33,000 people in the United States required HPN 
in 2010. 2 Most frequently, patients receiving HPN have diagnoses of short-bowel 
syndrome, inflammatory bowel disease, or cancer with bowel obstruction.3,4 
 Quality of life (QoL) is defined by the Food and Drug Administration (FDA) 
as a ‘general concept that implies an evaluation of the effect of all aspects of life on 
general well-being’.5 Factors that negatively affect the overall QoL of HPN patients 
are decreased physical, psychological and social function, along with increased 
occurrences of depression, drug dependency, sleep disturbance, frequent urination, 
fear of therapy-related complications, and inability to eat. 1,6-8 The emotional and 
physical complications associated with HPN and underlying disease require extensive 
lifestyle adaptation for patients and their families.9 Psychosocial factors include; 
coping with a medical diagnosis, being dependent on technology, coping with the loss 
of the eating experience, relying on others for care, low self-esteem, interfering with 
sexual functions, and the financial burden of nutrition support.10 The emotional and 
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physical adaptations required by this technology-dependent population emphasizes the 
necessity of support by a multidisciplinary medical team. This team should have the 
tools necessary to effectively communicate with their HPN patients as such support is 
crucial to patient-care and quality of life. One such tool is a Patient Reported Outcome 
(PRO) questionnaire, which serves to collect information from patients about existing 
psychosocial challenges as well as a management of their health condition.11  
 Winkler et al. 12 determined that HPN patients perceived their routine medical 
appointments as a parenteral nutrition “tune-up”, with sessions focusing primarily on 
medical or disease aspects of care. Patients self-reported that they desired a more 
holistic approach to parenteral nutrition management, incorporating physical and 
emotional support, in addition to medical examination and nutrition assessment.12 If 
used in clinical practice, PRO instruments could provide support to patients because 
feedback is provided to the clinicians with the goal of helping them manage patient 
care.11 Such instruments can be invaluable in facilitating patient-clinician 
communication around QoL.11 Although the use of PRO instruments in clinical 
practice can improve the interactions between patients and their clinicians, the Sustain 
Registry, a national patient registry for nutrition support, reports that <2% of enrolled 
HPN patients have had QoL constructs measured or assessed.4,11  
 There is one validated HPN-specific QoL instrument to assess the HPN 
population, the Home Parenteral Nutrition Quality of Life Questionnaire.13 This 
instrument has been used to score and assess changes in QoL among HPN patients 
receiving pharmacological interventions.13,14,15 However, the HPN-PROQ was 
developed with a different purpose in mind than that of the HPN-QoL. Rather than 
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producing an overall score of the patient’s QoL, the HPN-PROQ is an instrument that 
may enable a HPN patient to easily complete a PRO questionnaire in a clinical setting 
and prioritize important medical and non-medical issues for discussion with clinicians. 
 The purpose of this study is to assess the content validity of the HPN-PROQ. 
Once the instrument has undergone this rigorous content validation process and future 
studies conduct psychometric testing, and clinical validation, the HPN-PROQ could be 
applicable for use in the clinical setting with adult HPN patients residing in the United 
States. 
HPN-PROQ Development 
 The draft HPN-PROQ was developed after a comprehensive literature review, 
expert clinician feedback, and qualitative research by Winkler et al.1 , which explored 
the lived experiences of HPN dependent adults. Qualitative research revealed that GI 
symptoms (with or without an ostomy), eating and mealtimes, energy level and ability 
to do activities of daily living, sleep, psychosocial function and coping, and the 
complexity of technology and training for HPN, all influenced self-perceived QoL of 
HPN patients.1   
  The draft HPN-PROQ included two sections with a total of 54 items. Section 
One asked patients to report how often they experience specific situations during the 
previous two-week period. A four-point Likert response-scale was chosen for this 
section: “never”, “2-3 days per week”, “more than half of days”, and “nearly every 
day”. Constructs included: eating and mealtimes, psychosocial functioning and 
coping, HPN management, energy level and ability to do activities of daily living, 
sleep, and GI symptoms (36 items total). Items relating to GI symptoms were 
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differentiated by anatomy (ostomy or bowel in continuity). Section Two included 18 
true/false items. A four-point Likert response scale was chosen for this section: 
“mostly false”, “somewhat false”, “somewhat true”, and “mostly true”. Constructs 
included: QoL, living with HPN, and HPN equipment-related knowledge.  
  A crucial step in the development of questionnaires is to provide evidence that 
the items and scales possess content validity.5 When testing the content of a newly 
developed PRO, there are two primary components of importance.16,17 First, what is 
the intent of the question: what do respondents believe the question is asking? Second 
is the meaning of specific terms in the instrument: what do specific words and phrases 
in the instructions, items, and/or response options mean to respondents? Is that 
meaning consistent with the intent of the researchers?18 Because PRO instruments 
assess concepts most relevant and important to a patient, content validity must be 
established as it is the extent to which an instrument assesses the concepts it proposes 
to assess.18  
Figure 1 illustrates the process of content validation and where it falls in instrument 
development and validation. This figure has been adopted from Schildmann et. al.19  
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 **Steps denoted in white shaded boxes were completed in this study. 
Figure 1: Instrument Validation Process Flow 
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Methods 
This study assessed the content validity of the HPN-PROQ using a two phase 
mixed-method study design; qualitative methods and quantitative methods via the 
administration of the Content Validity Index (CVI).20 The purpose was to modify this 
draft based on cognitive interview (CIs) feedback from HPN patients (Phase I) 
followed by expert review with home care clinicians who completed the CVI (Phase 
II). (See Table 1) This study protocol was reviewed and approved by the University of 
Rhode Island’s Institutional Review Board (IRB) prior to the start of recruitment.  
Table 1: Content Validation Methods Process Flow 
*Start: draft HPN-PROQ 
Phase Method Sample Result 
I 
Qualitative 
 
Cognitive Interview & 
analysis of feedback to drive 
decisions for revision to 
draft. 
HPN Patients Modified draft HPN-PROQ 
II 
Quantitative 
 
Content Validity Index to 
determine “excellent” item 
and scale relevance of 
modified draft. 
HPN Expert 
Clinicians 
Content Valid HPN-
PROQ 
 
Sampling  
HPN patients 
 Similar to Chopy et al.21, the Oley Foundation, a national, independent, non-
profit 501(c)(3) organization serving HPN patients through education, advocacy, and 
networking, approved the study protocol and, agreed to post and distribute 
announcements calling for study volunteers. (Recruitment materials can be found in 
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Appendix E). Eligibility requirements for HPN patients included being 18+ years of 
age, receiving HPN, speaking English, living in the U.S., having an active email 
address, and ability to access a computer while simultaneously being on the telephone. 
Exclusion criteria included being pregnant and those receiving enteral nutrition. Study 
patients self-selected to participate by contacting the research email address. Each was 
sent the eligibility screener including seven questions to verify eligibility: “Do you 
live in the US?”, “What is your age in years?”, “Are you pregnant?”, “Are you 
receiving home TPN?”, “Do you speak English?”, “Do you have computer access?”, 
“Can you talk on the telephone and read on the computer at the same time?”.  A target 
number of cognitive interviews (n=30) was chosen by the research team prior to the 
start of Phase I. Demographic information included medical diagnosis, length of time 
dependent on HPN, number of infusions per week, number of infusion hours per day, 
age, sex, race, number of people in household, and highest level of education. 
Microsoft Office Excel (2017) was used for descriptive statistical analysis and results 
are reported as mean and frequency.  
HPN Experts 
 For Phase II, a convenience sample of expert HPN clinicians identified through 
publication (recognized contributions to the literature on the topic of HPN), leadership 
in the American Society for Parenteral and Enteral Nutrition home care section, and 
the Oley Foundation were asked to participate. The expert panel included physicians, 
registered dietitians, pharmacists, registered nurses, and home-care advocates. The 
goal was to recruit 12 experts as this is an acceptable sample size for completion of the 
CVI and is comparable to other studies.20,22-24 A reduced panel utilized a second round 
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of the S-CVI/AVG after analysis of full CVI panel results. This sample was also 
stratified by profession in order include input from commonly included members of a 
medical team who serve the HPN population. 
Data Collection Phase I: Cognitive Interviews  
 All interviews were audio-recorded on a Sony ICD-PX333 digital voice 
recorder and notes were taken during interviews to keep an audit trail and enhance the 
researchers’ understanding of the recorded conversations. During semi-structured 
interviews, a verbal probing cognitive interviewing technique was employed. 25 The 
interviewer used the following probes: verbal probes (“what does the term xyz mean to 
you”); paraphrasing (“please repeat the question I just read to you in your own 
words.”); recall probe (“how do you remember how often you experienced xyz in the 
past 2 weeks?”); and general probes (“would this be easy or hard to answer? I noticed 
that you hesitated - tell me what you were thinking”).26 Patient responses to probes 
served to guide the interviewer to probe more efficiently in future interviews and to 
collect more streamlined data. After all interviews, patients were asked to share their 
“overall impression” of the HPN-PROQ (i.e. if they felt the instrument would be 
useful in starting a conversation with any of their health-care clinicians.)   
 Recordings from each interview were transcribed verbatim, de-identified, and 
saved as Microsoft Word (2017) documents. The collaborative research team (CRT) 
met frequently throughout the qualitative data collection process to discuss potential 
revisions to the draft HPN-PROQ. In cognitive interviewing, data collection and 
analysis is an iterative, concurrent, and interrelated process. Patterns and themes were 
identified in an ongoing manner throughout Phase I.25  
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 A pilot interview was conducted to test the interview template/script and to 
establish an estimation of the time required to complete the interview. This interview 
was not recorded and data from this pilot interview are not included in results. 
Because of the length of the pilot interview (approximately 97 minutes), round-one 
CI’s were split into two sets. See Figure 2. Round-one interviews were conducted to 
evaluate the overall relevance, comprehensiveness and suitability of items, 
instructions, and response scales on the draft HPN-PROQ with the purpose of 
subsequently modifying the questionnaire based on interview feedback. Specifically, 
set one interviews (n=10) evaluated items Section One items 1-20 and set two 
interviews (n=10) evaluated items Section One items 21-36, and Section Two, items 1-
18. All round-one interviews tested the 4-point Likert response-scales included in the 
draft HPN-PROQ. 
 
 
Figure 2: Cognitive Interview Process Flow 
Round 1: Set 1  
CI's 1-10 
• Test Items  
Section One,  
1-20, 
instructions, 
response scale 
Round 1: Set 2 
CI's 11-20 
• Test Items Section One  21-36, Section 
Two items 1-18, instructions, response 
scale 
Round 2 
CI's 21-32 
• Test all 
modified items 
and response 
scales from 
Round 1 
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 Each patient received the draft HPN-PROQ via email 5-10 minutes prior to the 
interview call. Patients were not asked to complete the draft HPN-PROQ. During 
interviews, the researcher focused on the interpretation of the items rather than 
considering how the patient would respond. The method of returning analyzed data to 
a participant, known as member checking,  is often used to validate data collected in 
one interview by checking with another informant before subsequent interviews are 
conducted.27, 28,29 After first round interviews and prior to starting round two 
interviews, a second interview (member check) was conducted with all round one 
patients (n=20) to review some projected modifications to the draft HPN-PROQ. 
These patients were contacted via email and asked to participate in a “member check” 
interview to discuss proposed modifications to the questionnaire.   
 Following round one interviews and member checking, thematic analysis of 
interview data was used to inform all necessary revisions to the draft HPN-PROQ. To 
ensure a robust set of findings, the revisions to the draft HPN-PROQ were tested in 
round-two interviews. Round two patients (n=12) were sent the modified draft HPN-
PROQ and interviews were conducted to assess the clarity, relevance, and 
interpretation of the revised items and response scales. Patient feedback was again 
analyzed, and the CRT assessed the need for further revisions. Potential revisions to be 
included in the final draft were tested via member checking and in three final 
interviews. (i.e. interviews 29-32) 
 At the completion of Phase I, the CRT met to finalize all revisions before 
proceeding to Phase II. Qualitative data are presented and reported as representative 
quotes from HPN patients. 
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Data Analysis Phase I: Cognitive Interviews 
  Interview data were summarized and evaluated by the CRT and ultimately 
informed revisions to the draft HPN-PROQ. All decisions to change or modify any 
aspect of the questionnaire during Phase I were based solely on interview data and 
decisions made by the CRT based on these data.  
 Transcript contents were organized on an item-by-item basis using Microsoft 
Excel. By combining itemized patient feedback pertaining to each item, a cross-
interview data matrix table was developed to aggregate feedback across interviews and 
seek patterns that identify key findings. Thematic analysis was used to sort and 
condense these data into themes, support decisions for revision to the questionnaire, 
and identify non-problematic items. A “theme” serves to categorize data and 
represents a level of patterned responses or meanings within the data set. 30 Thematic 
analysis offers a “theoretically-flexible” approach to analyzing qualitative data and 
serves to organize a rich and detailed, yet complex account of data into meaningful 
results.30 Throughout this process, members of the CRT met frequently to discuss 
interview feedback and decide upon potential revisions to the draft HPN-PROQ. 
Careful consideration was given to vague or ineffective instructions, confusing 
questions and response options, variable interpretation of terms, general signs of 
misinterpretation by the patient and potentially reactive or offensive items.  
Data Collection Phase II: Content Validity Index 
 Following the completion of Phase I, a CVI Worksheet representing the 
modified draft HPN-PROQ (see Appendix G) was administered via email to 13 HPN 
expert clinicians who agreed to participate in the study. Each participant returned the 
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CVI worksheet to the research email address and data were entered in Microsoft Excel 
(2017) software for analysis. After determining any necessary deletion of items based 
on I-CVI criteria of ≥ 0.783, five experts (one physician, pharmacist, registered 
dietitian, registered nurse, and home care advocate) were chosen based on order of 
completion of round one CVI worksheets. (i.e. the first participant in each profession 
to complete the worksheet and return it to the research email was selected). These 
experts were sent a modified CVI Worksheet which excluded items not meeting the 
criteria for retention. Four experts returned the worksheet and data were entered in 
Microsoft Excel (2017) software for analysis. One expert clinician (registered nurse) 
did not respond to the research email with round 2 responses to the CVI.  
 Data Analysis Phase II: Content Validity Index 
 The I-CVI was calculated by having the experts rate the relevance of each item 
to the HPN population (1=not relevant, 2=somewhat relevant, 3=quite relevant, 
4=highly relevant). The I-CVI of each item is defined as the number of experts 
offering a rating of “3” or “4” on each item, divided by the total number of experts and 
expresses the proportion of agreement by all experts on the relevancy of each item, as 
number between zero and one.22 For example, an item rated as ‘‘quite’’ or ‘‘highly’’ 
relevant by four out of five expert clinicians would have an I-CVI of 0.80.  
 The I-CVI was then adjusted for chance agreements using a multi-rater kappa 
statistic proposed by Wynd et al.31 The kappa statistic represents the proportion of 
agreement remaining after chance agreement is removed.31 The multi-rater kappa 
statistic is described as follows. 
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Where Pc is the probability of chance agreement, n is the number of experts, and A is 
the number of approving with “good relevance”.31 K was calculated using the I-CVI 
and probability of chance agreement as follows:  
k∗ =  ICVI − Pc1 − Pc  
Each item on the scale was rated as “fair”, “good”, or “excellent” based on the 
following rating criteria: fair, K = 0.40-0.59; good, K = 0.60-0.74; excellent, K > 0.74. 
In the content validation of questionnaires, any item receiving a I-CVI kappa statistic 
≥ 0.783 is considered to have high relevance and should be retained, and any item 
receiving a kappa < 0.783 should be removed from the questionnaire.20 
  The Scale-CVI/AVG (S-CVI/AVG) was calculated using Microsoft Excel 
(2017) software. The S-CVI/AVG is the average I-CVI scores across all items.31  
SCVI/AVG =  ∑ICVIn  
Where n= the number of experts, a S-CVI/AVG over ≥ 0.83 is deemed acceptable in 
the content validation assessment of a newly developed instrument.20 If deletions 
occur as the result of the I-CVI, the S-CVI/AVG can be repeated with a reduced panel 
to demonstrate differences in these scores after modification to the questionnaire.31   
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Table 2: Demographic Characteristics of HPN Patients Participating in Cognitive 
Interviews (N=32) 
Female sex, % 71% 
White race, % 98% 
Marital Status, % married 61% 
Caregiver present, % 35% 
Highest Level of Education (n) Doctorate n=2 
Masters n=6 
Bachelors n=7 
Associates=2 
High School Diploma n=15 
 
Medical diagnosis relating to need for HPN 
(n) 
Short Bowel Syndrome n= 22 
Gastroparesis n=3 
Pseudo Obstruction n=4 
Intestinal malformation n=1 
Severe Food Allergy n=1 
Mitochondrial Disease n=1 
 
Number of people living in household, mean 
+/- SD (range) 2.4 +/-1.5 (1-7 people) 
Age (years), mean +/- SD (range) 52 +/-15 (22-73 years) 
Years on HPN, mean +/- SD 12.0 +/- 10.5 (1.2-34 years) 
HPN infusions per week, mean +/- SD 6.5 +/- 1.1 
HPN infusion hours, mean +/- SD  12.0 +/- 3.7 
*HPN=Home Parenteral Nutrition 
 
 
 
 15 
Results 
Phase I: Cognitive Interviews   
 Fifty-five adult HPN patients contacted the research email address indicating 
their interest in participating. Forty-three HPN patients replied to the screener email 
and 38 were determined eligible. Thirty-two patients comprised the study sample. 
Participant’s mean age was 52 years (+/- 15 years), 71% female (n=23), and 98% 
Caucasian (n=31) with a diagnosis of either short bowel syndrome (n=22), 
gastroparesis (n=3), pseudo obstruction (n=4), intestinal malformation (n=1) severe 
food allergy (n=1), or mitochondrial disease (n=1). All participants possessed at least a 
high-school diploma, and 46% (n=15) had achieved a bachelor’s degree or beyond 
(See Table 2). 
 The mean length of time for round one interviews was 51 (± 9) minutes and for 
round two interviews was 37 (± 10) minutes. Four themes were identified during 
qualitative data analysis.32 (see Appendix F). Based on this analysis, problematic items 
or response scales were revised or deleted.
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Concerns with tone: Patients voiced concerns about the phrases “normal lifestyle”, 
“controls my life”, and “limits my freedom”. These phrases elicited unfavorable 
comments, indicating the items’ tone may be overly negative. For example, the item 
“I am able to live what I consider a normal lifestyle” elicited the following comment 
from one patient who felt the item would be difficult to answer; “…this one is a little 
harder to answer… because I think normal is hard to define for everybody…that 
would need some parameters”. Another patient provided similar feedback; “…that’s 
kind of a hard one, because people have different lifestyles.” One bluntly stated; “I 
don’t live a normal lifestyle.”  
Issues with ambiguity and meaning: Across interviews, some items and phrases were 
inconsistently interpreted.  For example, several patients requested additional 
clarification around the meaning of the phrase “many times”. Several patients 
requested that the interviewer quantify what was meant by “many times”. One patient 
felt the question would be difficult to answer, “I would wonder about what you mean 
with ‘many’ times.” Clarification was needed on several occasions around the concept 
of being “satisfied or “coping”. For example, “I am satisfied with the amount of sleep 
I get” was difficult for some patients to conceptualize; “… someone can be satisfied 
with no sleep so it’s very individual”.  
Concerns with use of jargon or word choice: Patients voiced concern with the 
terminology used in some items. Patient feedback assisted in the refinement of these 
items to reflect more general terminology, or more commonly used terms and phrases 
in the HPN population. For example, the term “ostomy appliance”; one patient 
explained that this term is rarely used in their daily language, “…I have a big issue 
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with this. I tell my nurses when they ask me about changing my ostomy appliance that 
I don’t change it more than once a day but I empty it frequently… changing and 
emptying is two different things so I would change that.”. Another patient suggested 
the word “change” be revised to “empty”, “…change is not appropriate in here...you  
don’t change it, you empty the bag.”. When these changes were tested in subsequent  
interviews, patients agreed with this feedback, “I agree, I think I tend to call it a bag.” 
Table 3: Utility of the HPN-PROQ Representative Quotations 
“I think these questions are phenomenal. I think they nail it…doctors don’t ask 
that (these questions) ...but this feels so human and full empathy, I really 
appreciate this kind of questions”. 
“Yes, I think it (the HPN-PROQ) would benefit and give them (clinicians) an 
idea on how you’re doing on TPN, that broad questions show them how it’s 
affecting everyday of your life and not just how you’re doing right now.” 
 
“I do (feel the HPN-PROQ would be useful) provided a doctor actually takes 
the time to kind of divulge in these kinds of things. Most of the time they’re 
like “ok here’s your action and what you have to do” and the home nurse will 
explain it all to you. There’s not much (conversation) beyond that, the 
treatment plan…” 
“A lot of times the patients want to talk about how they feel, but the physicians 
don’t.” 
“They know the medical “in’s and out’s” in terms of intestine and bowel 
(issues) but they are clueless to what the TPN patient goes through 
emotionally and physically”. 
“Yes it (the HPN-PROQ) would spark a conversation…if you said you have a 
concern about your diet or diarrhea and they can offer you a dietitian.” 
 
“I think it’s excellent it gives somebody topics to focus on when you’re at the 
doctor and you have many questions to ask and they you go home and you 
remember that you forgot to ask some question… so I think it’s a great 
conversation starter to have them (patients) fill it (the HPN-PROQ) out and 
discuss it during the visit.” 
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HPN-PROQ Utility : Overall, patients provided very positive feedback regarding the 
use of the HPN-PROQ and were supportive of the development of the instrument. 
Patients described the draft HPN-PROQ as “useful”, and the items as “beneficial”, 
“human”, and “empathetic”. Representative quotations supporting this theme can be 
found in Table 3.  
Revision to Response Scales and Instructions: Across round one interviews, patients’ 
interpretation of middle response options of the four-point Likert Scale varied widely 
across interviews. For example, patients described the response option “2-3 days per 
week” as “…three to four days per week.”; “…maybe six times.”; “…I would say four 
days per week.”. The response option “more than half of days” was described as 
“...four days per week”, “more than seven days.”; “anywhere between eight to 13 
days”. These inconsistencies showed that revision to the response scale was necessary. 
The response-scales were changed to Visual Analog Scales (VAS) with the stems 
“Not at all” and “Every day” for Section One, and “Definitely false” and “Definitely 
true” for Section Two. The decision to use a VAS was based on review of relevant 
literature that indicated a VAS would be a suitable response scale for the intended 
utility of the HPN-PROQ.33 Revisions to the response scale were tested with all 
patients from round one interviews via member checking. One hundred percent of 
round one interviewees (n=20) participated in the member check, and the majority 
(n=16) agreed with the need to revise the response option and preferred the VAS to 
the Likert Scales. Patients described the VAS as “better”, “less time consuming”, “a 
great visual” and “more accurate”.  The VAS was included and tested in round two 
interviews. The instructional set for Section One was also revised; “please indicate 
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how often you experienced any of the following situations in the past two weeks” to 
“please estimate how often you experienced any of the following situations in the past 
two weeks”. This change was also tested via member checking and was found to be 
appropriate. 
Additional Revisions 
 In addition to the revisions driven by participant feedback and qualitative data 
analysis, structural changes to the draft HPN-PROQ were made by the CRT. Three 
items in Section 1 were moved to Section 2 (true/false). “I feel supported by my family 
and friends”, “I eat and enjoy the foods I want to eat”, “I am confident with my ability 
to perform TPN procedures on my own.”. These items were tested as true/false items 
in interviews 29-32. Participants agreed with this revision and felt the questions were 
better suited for section two of the questionnaire.  
 Other results of interest in this study are the patient’s interpretation of the item 
relative to the definition of QoL. Winkler’s definition of QoL for the HPN population, 
defined as “doing what I want to do when I want to do it”.1 Participants in our study 
agreed strongly with this QoL definition “doing what I want to do when I want to do 
it”.  This item was repeated verbatim by many participants and feedback supported 
this QoL definition in the HPN population. One patient stated “I think it’s very 
clear...it pretty much sums it up. I like that statement”. Another agreed by saying, “I 
think good quality of life means being able to do what I want do”.  
Summary 
 Many items (n=29, 54%) were described as “understandable”, were deemed 
acceptable, and viewed as comprehensible, acceptable, “clear” and “easy to answer”. 
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These items were interpreted as intended by the researchers and participants 
consistently rephrased them verbatim. These items did not require revision and were 
retained, whereas items or response scales viewed by participants as being problematic 
were revised or deleted from the instrument (deleted; n=11, 20%, revised; n=14, 25%). 
The modified draft HPN-PROQ tested in Phase II contained 43 items and included 
two sections: Section One (24 items) with a VAS response scale (stems “Not at all”; 
“Every day”). Section Two (18 items) with a VAS response scale (stems “Definitely 
false”; “Definitely true”).  
Phase II: Quantitative CVI 
 Thirty-three home care clinicians were invited to participate in the expert panel 
CVI. Thirteen expert reviewers, stratified by profession (physicians n=2, pharmacists 
n=3, registered dietitians n=3, registered nurses n=2, home care advocates n=3), 
agreed to complete the CVI with the modified draft HPN-PROQ. The first participant 
from each profession to complete the I-CVI from round one was selected for round 
two of the S-CVI/AVG. This sample included one physician, one registered dietitian, 
one pharmacist, and one homecare advocate.  
 Individual, adjusted, multi-rater kappa scores were examined for each of the 
items on the modified draft HPN-PROQ following cognitive interviews. Thirty-four 
items scored as “excellent”, with an I-CVI score ≥ 0.783, and nine items were deleted 
based on a I-CVI score < 0.783, indicating low relevance to the HPN population .34 
See Table 4 for an item by item analysis of the I-CVI.  
 The S-CVI /AVG score was calculated in two rounds: prior to modification 
based on I-CVI analysis and again after the removal of the nine items not meeting 
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criteria for relevance. The S-CVI/AVG score improved from 0.91 in round-one to 0.96 
in round two. The final S-CVI/AVG score was > 0.80, which is considered acceptable 
for the content validation of newly developed PRO questionnaires.20  
Discussion   
 Patient reported outcome questionnaires serve to increase awareness on both 
the patients’ and clinicians’ behalf, as they facilitate discussion around QoL 
constructs, treatment plans and goals, and patient knowledge of caring for their 
medical condition and/or treatment.35 There are many factors affecting the QoL of 
HPN patients, signifying the need for clinicians to have the tools necessary to support 
their patients not only medically, but also psychosocially. Researchers have concluded 
that assessment of QoL in this population should be facilitated using a therapy-specific 
instrument.1, 10, 36 Currently, only one validated QoL instrument exists to clinically 
evaluate the HPN patient, however, use of this instrument has only been published in 
research studies thus far.14, 15 The HPN-PROQ was developed with patient-clinician 
communication in mind. Once validation procedures such as content validity, clinical 
relevance testing, and psychometric validation, are completed, the HPN-PROQ could 
be used to foster communication between the patient and clinician around issues 
impacting their QoL. The purpose of this study was to demonstrate the content validity 
of the newly developed HPN-PROQ in a sample of adult HPN patients in the U.S. 
 Presently, the HPN-PROQ may be more suitable for use in clinical practice in 
the U.S. than the only other instrument, the Home Parenteral Nutrition Quality of Life 
(HPN-QOL©) given the in-depth involvement of adult U.S. HPN patients and 
clinicians in both the generation of items and in the content validation of the 
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questionnaire. Additionally, the HPN-QOL© has only been validated in European 
cultures, and therefore may not be applicable for use in the United States.37 Another 
critical difference between the HPN-QOL© and the HPN-PROQ is that the HPN-
QOL© is designed to be a scored instrument, i.e. generates a number that can be 
compared over time and/or with other populations (normal/well or disease-specific). 
The HPN-PROQ does not produce a score, but instead allows a subjective approach to 
the evaluation of issues that may impact QoL. Use of the HPN-PROQ could help 
patients prioritize specific areas that they may wish to discuss with their clinician. It 
also allows patients the opportunity to explain their concerns to their clinician in more 
detail and discuss why they are feeling the way they are feeling.  
 The VAS response scale makes this questionnaire a more “user-friendly” 
instrument for both patients and clinicians than a Likert Scale. 33 Use of VAS in the 
clinical setting with self-administered questionnaires is common.38 Visual Analog 
Scales are frequently used to evaluate pain, mood, and patient satisfaction, are 
advantageous in that they are less vulnerable to bias from confounding factors linked 
to Likert scales (i.e. ambiguity of response descriptors/options), and require less time 
to complete.33 Our sample of HPN patients expressed a preference for the VAS and 
considered the VAS superior to the Likert Scale. They noted that the VAS would be 
“easier to use”, a “good visual”, and “possibly more accurate”. Because the purpose of 
the HPN-PROQ is to facilitate discussion rather than produce a final score, the VAS 
may provide a better “snap shot” than what could be obtained with a Likert scale. The 
HPN-PROQ de-emphasizes the significance of overall/total scores and may turn 
attention to factors influencing QoL and lifestyle adaptation with HPN. This could 
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allow for clinicians to pay attention to individual response patterns to decide what type 
of care is needed. Because patients may be embarrassed or hesitant to initiate 
conversations with their clinicians around psychosocial issues, having the HPN-PROQ 
may facilitate discussions between clinicians and their patients. 
 Validation of newly developed instruments is a rigorous process which 
includes the establishment of content validity.18 The importance of content validity in 
developing PRO instruments is emphasized by both the US Food and Drug 
Administration and the European Medicines Agency 5, 39. The US Food and Drug 
Administration also highlights the importance of including substantial patient input in 
PRO development.5 We have included a target population of HPN patients and an 
iterative qualitative research process to confirm content validity.5 Although addressing 
all concerns and suggestions made by every participant was not possible, 
demonstration that the new PRO instrument is understandable to potential respondents 
is essential in evaluation of content validity.18  
 Cognitive interviewing is commonly employed to improve the content validity 
of newly developed PRO instruments because they should utilize common terms 
understood by the target population. In this study, results from cognitive interviews 
demonstrated that many items were understood by HPN patients in the original form 
written, were interpreted by HPN patients as intended by the researchers, and were not 
found to be difficult to recall or challenging to answer. HPN patients provided several 
suggestions in relation to word-choice and issues with jargon. Cognitive interviewing 
is an evidence-based technique to assist researchers in providing content validity-
evidence by assessing the participants interpretation of items during interviews.40 It is 
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important to recognize that data collected from cognitive interviews are qualitative in 
nature and are mainly used to assess and improve questionnaire items before the 
questionnaire is implemented.41 Cognitive interviewing requires a level of 
understanding of patient issues alongside the ability to listen, interpret, and accurately 
report patient comments; none of which are reflected in quantitative research.42 
Although not frequently reported in the same detailed or robust manner as in this 
study, many content validation studies use cognitive interviewing in the target 
population as a means to improve validity.13, 14, 42, 43, 44, 46    
 We identified item-specific issues with lack of clarity regarding word choice, 
comprehension, and ambiguity and uncovered potentially problematic items and terms 
not previously identified in HPN-QOL© validation studies. For example, patients 
suggested using “central line” to replace “catheter” and “emptying an ostomy bag” 
instead of “changing the appliance”. This study builds upon the validation of the HPN-
QOL© by informing researchers of the value of patient input in questionnaire 
development and validation.  
 This study possessed many strengths, one being the combination of qualitative 
and quantitative methodology. This study possesses rigor in qualitative research which 
was accomplished by having a sound scientific methodology and protocol, which 
included semi-structured interview scripts, appropriate analysis of the data, and 
documentation of findings.42 The use of quantitative data in the absence of thorough 
collection of knowledge, frameworks, and qualitative considerations can potentially 
produce a clinically ineffective instrument. It also should be recognized that the use of 
qualitative data alone to substantiate an instrument may be rhetorically convincing, but 
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scientifically incomplete.18 Keeping in mind the broader patient-centered philosophy, 
collaboration with the target population in early development and validation stages can 
ensure effective handling of sensitive content, and possibly prevent attrition that could 
result from invasive or offensive content.45  
 Cognitive interview projects are normally small in scope and may involve just 
10 participants. 13, 14, 42, 43, 44, 45 Characteristics of the sample should reflect as closely as 
possible the patient population to be included in future studies that will incorporate the 
PRO.48 This study conducted two rounds of interviews to provide ample opportunity 
for problematic items to emerge.32  The target sample for this study was adult patients 
receiving HPN. The demographics, diagnoses, length of time receiving HPN, and 
length of infusion schedule compares favorably to similar studies. 4,21 Demographic 
data from in our sample is comparable to the Sustain Registry in that short bowel 
syndrome was the primary indication for HPN adults (28.7%) and the Sustain cohort 
was predominantly female (59%) and Caucasian (75%).4 Our sample was also 
homogenous (98 % Caucasian, 71% female) and our sample size of 32 was 
comparable, if not stronger than, other published sample size criteria for content 
validation via qualitative methods.18 It was determined during review of transcripts 
and analysis that data saturation was achieved in our sample (n=32). Data saturation is 
the point in data collection and analysis when new feedback no longer contributes 
significant information. 32 
 Five experts or more are required to have a valid sample for CVI.20 We 
exceeded this target as well as stratified our sample by profession given the multi-
disciplinary team often involved in the care of HPN patients.  Our sample included 
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clinicians with experience managing HPN, two physicians, three pharmacists, three 
registered dietitians, two registered nurses, and three home care advocates. HPN 
expert home care clinicians rated most items as having “excellent” relevance, leading 
to a highly acceptable S-CVI/AVG score. The I-CVI of the items on the HPN-PROQ 
were analyzed using conservative criteria for retention; only the items accomplishing a 
kappa I-CVI rating ≥ 0.783 were retained resulting in the deletion of nine items. The 
final overall S-CVI/AVG was 0.96. This as an acceptable score and is comparable to 
the results of other content validation studies.23, 24, 34, 44  
 The results and methodology of this study are consistent with similar content 
validation studies using the CVI to determine content validity of a newly developed 
questionnaire. The Osteoporosis Risk Assessment Tool (ORAT), eight experts were 
selected from nationally known clinicians and researchers holding well-respected 
reputations in the area of osteoporosis risk prevention and treatment.48 This study used 
an acceptable level of relevance score of 0.58 to determine item relevance and criteria 
for the deletion or retention of items on a draft questionnaire.48 In the development and 
content validation of an instrument for measuring patient-centered communication, 
fourteen designated experts completed the CVI using a modified kappa statistic to 
quantify item relevance.23 Compared to our study, researchers in this study used a 
more liberal CVI criteria (>0.70) to determine item retention; resulting in the removal 
of 4 items from the prototype questionnaire. Similar to this study and by using a 
slightly smaller sample (n=9), Larsson et al.24 used the CVI in the validation of a 
muscle endurance questionnaire with an I-CVI criteria of (>0.78) to indicate 
“excellent” relevance; resulting in the deletion of fourteen items.  
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 Five items in Section One of the modified HPN-PROQ were slightly lower 
than criterion for retention based on the I-CVI. (i.e. they scored at 0.77 vs. 0.78). 
While this reduces the number of items on the questionnaire and decreases participant 
burden, elimination of these items may leave out some important constructs of HPN-
related quality of life. The CRT thought that these items’ topics are sufficiently 
covered by other items included in the questionnaire that were not eliminated. For 
example, I am able to walk up and down the stairs without difficulty” was eliminated 
but this topic could be sufficiently assessed by “I am able to walk without difficulty”. 
Three items pertaining to patients’ experiences with eating (i.e. bloating, pain, cramps 
as the result of consuming foods) were deleted from the questionnaire due to I-CVI 
scores. This does not mean to imply that this construct is irrelevant to the HPN patient 
population, as numerous studies have demonstrated its importance.1,3,6,7 It should be 
noted that these items represent aspects of eating that are physical in nature, rather 
than psychosocial in nature, and two remaining times assessed eating-related issues, 
justifying the removal of these items from this QoL instrument. However, in future 
clinical validation studies, clinicians and patients may find that these physical food-
related issues are relevant and therefore should be included in the HPN-PROQ. By 
design, the CRT felt that the general nature of some items retained on the 
questionnaire could be useful to cue the physician to ask the patient to describe more 
specifically what they are struggling with. This fosters the one main purpose of the 
HPN-PROQ, which is to drive these conversations between the patient and the 
clinician.  
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 PRO instruments can enhance patient–clinician communication and inform 
plans of care to better target interventions that will improve patient outcomes. 50, 51 
Evidence from randomized controlled trials suggests that the use of PROs in clinical 
practice is valuable in improving the discussion and detection of QoL constructs, but 
has less of an impact on how clinicians manage patient problems or on subsequent 
patient outcomes.35 Many of the reasons for this may lie in the ways in which PROs fit 
(or do not fit) into the routine ways in which patients and clinicians communicate with 
each other, how clinicians make decisions, and how healthcare is organized. 
Greenhalgh et al.35 suggests future research should seek to identify ways in which 
PROs can be better incorporated into the routine care of patients by combining 
qualitative and quantitative methods. Regardless, use of PRO instruments can provide 
several advantages: as a means to alert the clinician to the patient’s concerns about 
their QoL, to clarify via discussion the patient’s priorities for care, and to facilitate 
conversation between patients and clinicians about these issues.50 This is especially 
important as patients and physicians do not always agree on which outcomes of care 
are most important.51 For example, patients with multiple sclerosis and possibly those 
with other chronic diseases are less concerned than their clinicians about 
physical disability in their illness and are more concerned with issues impacting their 
QoL.52 Studies have also shown that provision of PRO feedback to clinicians results in 
an increase use of health services and referrals, more timely reporting and 
management of symptoms, less patient anxiety, fewer preventable emergency room 
and office visits or calls, greater patient adherence to advice, greater satisfaction with 
care, more effective self-management, and more efficient use of resources. 49, 53, 54 
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 The HPN-PROQ illustrates acceptable quantitative and qualitative indices for 
content validity, as determined by HPN patients and expert home care clinicians.20 
Future quantitative validation of the revised scale and items should be considered 
alongside a large sample of HPN patients to provide quantitative support for the 
conceptual framework of the HPN-PROQ, specifically, it will be important to compare 
results from the HPN-PROQ to the HPN-QOL©. Clinical validation should also be 
conducted to assess the impact of the HPN-PROQ on treatment decision making. 
Specifically, future studies should include observations of patient-clinician interaction 
while using the HPN-PROQ with an assessment of patient and clinician satisfaction 
and communication. Lastly, all PRO instruments should be translated into different 
languages, including forward and backward translation methods.18 Many healthcare 
settings serve diverse populations with diverse language preference. Translation of the 
HPN-PROQ into other languages would prevent a relative or friend having to translate 
the questionnaire to the patient, potentially interfering with validity. 
Limitations 
 There are some limitations in content validity studies that should be noted. 
Expert feedback is subjective, and may introduce biases to the study, that may exist 
among the experts. Additionally, there was a demographic limitation in the CI sample 
which had a high rate of Caucasian females (71%). However, there is no reason to 
suspect that this would impact our data in a way that would impair the clarity, 
relevance, and acceptability of the revised components of the HPN-PROQ. Selection 
bias is likely as participants were self-selected, interested, and willing to participate. 
Lastly, this study was conducted with adult HPN patients only and therefore, results 
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are not generalizable to pediatric patients or their parents or caregivers. [most parents 
or caregivers act as proxy for young children who cannot complete QoL or other 
questionnaires.] Future studies should incorporate these populations.  
Conclusion 
 To the best of our knowledge, this study adheres to standard procedures in 
content validation and our data provides evidence that the final version of the HPN-
PROQ is a content valid questionnaire with relevant, clear, and refined items and 
response scales. We are confident that the HPN-PROQ meets the standards set forth 
by the FDA in terms of content validity, item readability, and understanding for the 
development of a PRO instrument. Cognitive interviewing, member checking, and 
calculation of the CVI were utilized to demonstrate the content validity of the HPN-
PROQ. The methodology used in this study (i.e. interview scripts, iterative analysis, 
actions taken to delete or modify an item in response to the cognitive interviews, and 
member checking) are appropriate to assess content validity.18 These methods help 
provide a valid set of items which will in-turn increase the likelihood of reliable 
responses from HPN patients.18  Overall, the majority of items included in the original  
HPN-PROQ were understood by HPN patients and interpreted as intended by the 
researchers. The questions were described as “clear” and “easy to answer” and 
represented important areas in the lives of HPN patients.1  
 Although the primary intent of the cognitive interviews was to evaluate if HPN 
patients in our sample understood the items and could offer congruent interpretations, 
we also further identified the patient need for a HPN therapy specific instrument to 
support the HPN population in clinical practice. Patients frequently expressed their 
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gratitude for the work of project and were eager to participate; repeatedly commenting 
on the relevance of the issues raised in the HPN-PROQ and how effectively 
communicating with their clinicians about these issues is meaningful to them. This 
study found that patients perceived the need for an instrument such as the HPN-PROQ 
which could be used to facilitate communication among HPN patients and their 
clinicians to assist in the improvement of patient-care. 
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Table 4: Content Validity Index Data Quantitative Analysis 
Item  
Number of Experts 
giving a rating of a 
“3” or “4” 
k 
 Section 1   
 
1. I felt like my health limited the things I want to do in my life. 13 1.00 
2.  Being on TPN was difficult to cope with emotionally. 13 1.00 
3.  My daily activities were limited by my TPN infusion schedule. 11 0.85 
4. * Carrying my TPN solution limited what I could do. 10 0.77 
5. * I felt physically strong. 10 0.77 
6. I was able to participate in the activities I enjoy. 12 0.92 
7. I was able to walk without difficulty. 11 0.85 
8. * I was able to climb up and down stairs without difficulty. 9 0.69 
9. I was able to rise from a chair or bed without difficulty. 12 0.92 
10.* I was able to pick up an object from the floor without difficulty. 8 0.62 
11.* I needed to nap when I felt tired. 7 0.54 
12. I had enough strength and stamina to do daily chores or work. 12 0.92 
13. The TPN pump disrupted my sleep.  13 1.00 
14. 
My sleep was disrupted because I 
had to get up to move my bowels 
or empty my ostomy bag. 
12 0.92 
15.  My sleep was disrupted because I had to get up to urinate. 13 1.00 
16. I ate comfortably in social situations and around others. 12 0.92 
17.* Eating caused me to have gas or feel bloated. 10 0.77 
18.* Eating caused me to have pain. 10 0.77 
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Item  
Number of 
Experts giving a 
rating of a “3” or 
“4” 
k 
 
19. I had episodes of uncontrollable diarrhea. 12 0.92 
20.* I had to move my bowels shortly after I ate food. 10 0.77 
21.  
I had to rearrange my daily plans 
because of how much diarrhea I 
had. 
12 0.92 
 
22. I had episodes of uncontrollable ostomy leakage. 13 1.00 
23. * I had to empty my ostomy bag shortly after I ate food. 9 0.690 
24.  
I had to rearrange my daily plans 
because of how much ostomy 
output I had. 
13 1.00 
  
Section 2 
 
1. 
Good quality of life means being 
able to do what I want to do when I 
want to do it. 
11 0.85 
2. I eat and enjoy the foods I want to eat. 11 0.85 
3. 
I am confident in my ability to 
perform TPN procedures on my 
own. 
13 1.00 
4.  Having one or more nights or days without TPN is important to me. 13 1.00 
5. Having a shorter TPN infusion schedule is important to me. 13 1.00 
6.  
I feel relieved knowing my 
nutritional needs are being met by 
TPN therapy. 
13 1.00 
7.  
I am fearful of developing 
complications related to my TPN 
therapy and/or central line. 
12 0.92 
8.  I understand my need for being on TPN therapy. 13 1.00 
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Item  
Number of Experts 
giving a rating of a 
“3” or “4” 
k 
9.  
I know and have been 
trained on how to manage 
my TPN therapy. 
13 1.00 
10.  
I know and have been 
trained on how to care for 
my central line. 
13 1.00 
11. 
I know and have been 
trained on how to use my 
pump. 
13 1.00 
12. 
I know and have been 
trained on the signs and 
symptoms of a central 
line infection. 
13 1.00 
13.  
I know and have been 
trained on the signs and 
symptoms of dehydration. 
13 1.00 
14. 
I know and have been 
trained about my diet and 
what I should be eating. 
13 1.00 
15. 
I know whom to call 
when I have questions 
about my TPN therapy. 
13 1.00 
16. 
I feel emotionally 
supported by my family 
and friends. 
12 0.92 
17. I feel well supported by my home care specialists. 13 1.00 
18. 
I received information 
about local or national 
support groups for TPN 
therapy. 
13 1.00 
19. I wish I knew more about my TPN therapy. 12 0.92 
NOTE: I-CVI: item-level content validity index, **pc (probability of a chance occurrence) was 
computed using the formula: pc= [N! /A! (N -A)!] *.5Nwhere N= number of experts and A= 
number of panelists who agree that the item is relevant. Number of experts=14, ***k (modified 
kappa) was computed using the formula: K= (I-CVI- PC)/(1- PC). Interpretation criteria for 
kappa, using guidelines described in Polit et al. 20an item is considered “excellent” if k >0.780. 
Any item not meeting this criterion was deleted from the final HPN-PROQ. *Item 
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Appendix A: Literature Review 
Introduction 
 A patient reported outcome (PRO) questionnaire may enhance a clinician’s 
awareness of factors influencing a patient’s ability to adapt and cope with receiving 
long-term parenteral nutrition as their purpose is to collect quality of life (QoL) 
information.1-3 Currently, there is one validated tool to support the Home Parenteral 
Nutrition (HPN) population, the Home Parenteral Nutrition Quality of Life 
Questionnaire (HPN-QoL)©.4 However, according to published reports, this tool has 
only been used in research studies thus far.4-6 For this reason, the Home Parenteral 
Nutrition Patient Reported Outcome Questionnaire (HPN-PROQ) was developed for 
patients to self-assess aspects of their lives; aspects they may want to consider 
discussing with their HPN clinicians. Patient responses on the questionnaire are to be 
used to facilitate discussion between the HPN patient and clinician regarding patient 
goals and lifestyle adaptation. The aim of this study was to determine the content 
validity of the HPN-PROQ though cognitive interviewing with HPN patients and 
computing the Content Validity Index (CVI) with HPN expert clinicians. 
 Content validity must be established as part of the development phase of new 
PRO instruments.7 Content validity is defined as the extent to which a new instrument 
congruently measures aspects of a patient’s life; this can include aspects both medical 
and non-medical in nature.7 This literature review will broadly cover indications of 
HPN and QoL with a more in-depth review of the processes involved in PRO 
development, the application of cognitive interviewing (CI) and the Content Validity 
Index (CVI) in content validation, and the use of PRO instruments in clinical practice. 
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Home Parenteral Nutrition 
 Parenteral nutrition is a complex therapy involving the intravenous infusion of 
nutrients and fluids to individuals who have intestinal failure or dysfunction.8 Most 
frequently, these patients carry diagnoses of short-bowel syndrome, inflammatory 
bowel disease, or cancer with bowel obstruction.9,10 Over the last three decades, the 
expansion of home-health and nutrition support agencies have allowed HPN to 
become the primary treatment for patients who require long-term parenteral 
nutrition.11 Home parenteral nutrition should be used exclusively with patients who 
cannot meet their nutritional requirement by enteral intake, and who are able to 
receive therapy safely outside the acute care setting.12,13   
 It is estimated that 33,000 people in the United States required HPN in 2010.14 
The likelihood of being weaned from HPN is significantly reduced after 3 years and 
20-30% of patients require permanent treatment.15 Home-based care provides patients 
the opportunity to a receive complex therapy in a familiar and comfortable 
environment, with support from family members and trained healthcare 
professionals.16 Furthermore, patients benefit from home-based care as it provides 
improved QoL and comes at a lower cost than inpatient parenteral nutrition.16,17   
Quality of Life  
 Quality of life is defined by the Food and Drug Administration (FDA) as a 
‘general concept that implies an evaluation of the effect of all aspects of life on 
general well-being’.18 Health-related quality of life (HrQoL) is composed of multiple 
domains that comprehensively measure the patient's experience of symptoms (i.e. 
functional status, and psychosocial elements) against the patient's expectations and to 
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quantify the extent to which the burden of disease impacts a patient's quality of life.19 
Due to the complex technology of HPN as well as the underlying intestinal disease, 
QoL is thought to be poorer in individuals receiving HPN compared to patients with 
intestinal diseases who do not require nutritional support.10 Practical daily life 
restrictions and physical parenteral nutrition-associated complications may negatively 
affect quality of life (QoL).17  
 Roskott et al.11 determined that although HPN patients have a variety of 
different somatic symptoms, psychosocial problems have the greatest negative impact 
on QoL. Psychosocial factors include coping with medical diagnosis, being dependent 
on technology, coping with the loss of the eating experience, relying on others for 
care, low self-esteem, interfering with sexual functions, and enduring the financial 
burden of nutrition support.8 Home parenteral nutrition patients also experience 
decreased physical, psychological, and social function along with increased 
occurrences of depression, drug dependency, sleep disturbance, frequent urination, 
fear of therapy-related complications, and inability to eat.8,16,20 All of these factors 
may affect the QoL if a HPN patient. 
 When patients are discharged on HPN, support is available for HPN patients 
who are adjusting to HPN dependence outside of the clinical setting. Via membership 
of support and educational organizations, such as the Oley Foundation patients can 
actively participate in the HPN community, blogs, and research projects, and receive 
newsletters and educational information. Studies have shown that membership in such 
an organization is valuable the QoL of HPN patients.21,22 The Oley Foundation offers 
resources such as education, support groups, and workshops to HPN patients, and their 
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caregivers and families clinicians play a key role in introducing their patients to 
organizations such as the Oley Foundation.21 In addition to helping patients adjust to 
complexities of HPN therapy nutrition support.21 Support in the clinical setting is also 
important in the management, success, and quality of life of the HPN patient. Roskott 
et al.11 reported on the importance of offering psychosocial and medical support for 
fatigue, sleeping disorders, anxiety, depression, and social isolation, to improve QoL. 
However, research by Winkler et al.23 demonstrated that HPN patients perceive their 
routine medical appointments with their clinicians as a parenteral nutrition “tune-up”, 
and reported that with session focus primarily on medical or disease aspects of care. 
Patients self-reported they desire a more holistic approach to parenteral nutrition 
management, incorporating physical and emotional support, in addition to medical 
examination and nutrition assessment.23  
 Clinicians have serious concerns about the QoL of their HPN patients but are 
in need of guidance assessing the nature and severity of individually experienced 
problems.24 Baxter et al.24 demonstrated the need for HPN-specific questionnaire to 
support the HPN population and subsequently developed the Home Parenteral 
Nutrition Quality of Life questionnaire (HPN-QOL©) for the measurement of QoL in 
the HPN population. However, the use of this instrument has only been reported in 
clinical trials and research studies thus far.4-6 Furthermore, findings from the Sustain™ 
National HPN Registry demonstrate lack of routine assessment of QoL in the 
management and care of HPN patients in the U.S.9  
 Of difference between the HPN-QOL© and the HPN-PROQ is the HPN-
QOL© is a scored instrument, i.e. generates a number that can be compared over time 
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and/or with other populations (normal/well or disease-specific). The HPN-PROQ does 
not produce a score, but instead allows a subjective approach to the evaluation of 
issues that may impact QoL. Use of this tool helps patients prioritize specific areas 
that they may wish to discuss with their clinicians and allows patients the opportunity 
to explain their concerns and qualify why they are feeling the way they are feeling to 
their clinician in more detail. The HPN-PROQ is a necessary and novel instrument 
which should be used to facilitate communication among HPN patients and their 
clinicians to assist in the improvement of patient-care and interventions aimed at 
supporting the HPN population.  
Patient Report Outcome Instruments 
 Overall, research within and outside the HPN population strongly supports the 
use of PRO’s in clinical practice.24 Patient reported outcomes instruments collect 
information from the patient about a health condition and its management, including 
QoL constructs.25 Traditional applications of PRO instruments are in clinical research 
and health services research, although use in clinical practice is increasing.25 Many 
PRO instruments are self-administered questionnaires. They are given directly to the 
patient without the intervention of a clinician and without a third party’s 
interpretation; making them more reliable than observer-reported measures because 
they are not affected by inter-observer variability.18  
 In the clinical practice setting, PRO instruments are used as screening tools, 
monitoring tools, decision aids, and as a method of facilitating communication 
amongst multi-disciplinary teams.26 The potential use of PRO instruments in clinical 
practice to improve the interactions between patients and their clinicians is 
 44 
promising.27 When used in clinical practice, feedback is provided to the clinicians with 
the goal of helping them manage patient care.27 Detmar et al.2 found that incorporating 
standardized QoL assessments in daily clinical oncology practice facilitated 
discussions of HR-QoL issues and heighten physicians' awareness of their patients' 
HR-QoL. Two recent trials measured clinician–patient communication and determined 
there was an increase in the number of times HR-QoL issues were discussed in the 
consultation following PRO feedback.28,29  These discussions could lead to patients 
becoming more involved in decisions about their care thereby increasing their self-
efficacy to manage their own health.26 
  Not only have investigators found positive results with the use of standardized 
PRO instruments in facilitating patient-clinician communication, they also improve 
clinicians’ understanding of patients’ problems--particularly those of a psychosocial 
nature.25 Provision of PRO feedback to clinicians also results in an increase use of 
health services and referrals, more timely reporting and management of symptoms, 
less patient anxiety, fewer preventable emergency room and office visits or calls, 
greater patient adherence to advice, greater satisfaction with care, more effective self-
management, and more efficient use of resources.30,31,32 Having information on 
patients’ functioning and well-being alongside their laboratory results, imaging 
studies, and treatment notes, allows clinicians to see a more complete picture of the 
patient’s status.27  
Development of New PRO Instruments 
 This process begins with item generation based upon data from literature 
review, focus groups, or interviews with paitent.18 It should be noted that PRO 
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instrument item generation is incomplete without patient involvement, and should 
incorporate a wide range of patients to represent variations in severity and in 
populations characteristics such as age and sex.18 Keeping in mind the broader patient-
centered philosophy, collaboration with the target population in early development and 
validation stages can ensure effective handling of sensitive content, and possibly 
prevent attrition that could result from invasive or offensive content.33 The US Food 
and Drug Administration also highlights the importance of including substantial 
patient input in PRO development.18 Choice of data collection method and choice of 
recall period typically follow item generation and is usually determined according to 
the intended purpose of the questionnaire.18 The rationale for choosing these 
components should be evaluated; showing consideration for a patients ability to 
accurately recall the information requested, the characteristics of the disease/condition, 
and the treatment received.18 
 Choice of response options should include clear wording, clear distinction 
between choices, be appropriate for the target population, and come with adequate 
instructions. Ceiling and floor effects should be kept in mind, and avoided. Response 
options should also avoid directional bias.18  Use of VAS in the clinical setting with 
self-administered questionnaires is common.34 Baxter et al.24 found that QoL 
questionnaires currently being used in the HPN population can be grouped into three 
categories; generic and applicable to a rand of diseases of populations; those which are 
disease specific, and those which are non-validated. Of the three validated tools in this 
study (Short Form 36, EuroQol EQ5D, and the Sickness Impact Profile), all make use 
of a VAS.24 Visual Analog Scales are frequently used to evaluate pain, mood, and 
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patient satisfaction, and are advantageous in that they are less vulnerable to bias from 
confounding factors linked to Likert scales (i.e. ambiguity of response 
descriptors/options) and require less time to complete.35 Visual analog response scales 
makes questionnaires a more “user-friendly” instrument for both patients and 
clinicians. 35 Lastly, in pain assessment, VAS scales are more sensitive and a better 
measure of magnitude than descriptive scales. The Irritable Bowel Disease Control 
questionnaire also utilizes a VAS. 
Content Validation 
 Validation of newly developed instruments is a rigorous process which 
includes the establishment of content validity.7 The importance of content validity in 
developing PRO instruments is emphasized by both the US Food and Drug 
Administration and the European Medicines Agency18,36. The International Society for 
Pharmacoeconomics and Outcomes Research (ISPOR) Board of Directors approved 
the formation a the Patient Reported Outcomes Content Validity Good Research 
Practices Task Force to develop a good research practices report addressing methods 
for documenting the content validity of newly developed questionnaires7.  
 When testing the content of a newly developed PRO, there are two primary 
components of importance.37,38 First, what is the intent of the question: what do 
respondents believe the question is asking? Second is the meaning of specific terms in 
the instrument: what do specific words and phrases in the instructions, items, and/or 
response options mean to respondents? Is that meaning consistent with the intent of 
the researchers? Is it relevant to the concept of interest? Does it raises new content 
important to the concept of interest and/or new content not reflected in the instrument 
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as it is currently designated? If problems are identified, this will result in the revision 
of the draft instrument, followed by a new round of cognitive interviewing to test said 
revesions.38  
Cognitive Interviewing 
 After item generation, reporting evidence of content validity for a new PRO 
should be address in the processes taken for gathering evidence that persons in the 
target population understand the instruments structure and content. Patient-reported 
outcome questionnaires must include concepts and language relevant to patients and 
be easily understood. To improve content validity specifically, PRO instruments 
should utilize common terms understood by the target population. The technique of 
cognitive interviewing (CI) can be used to conduct a systematic, in-depth approach in 
assessing the validity of a questionnaire’s content and instructions. Cognitive 
interviewing is an evidence-based technique to assist researchers in providing content 
validity-evidence by assessing the participants interpretation of items during 
interviews.39 This process is often done as part of preliminary development, in the 
pretesting phase, prior, and to distribution in the field.33,40-44 This method is employed 
to test the relevance, comprehension, sensitivity, and the acceptability of the items.40 
Overall, this process and analysis allows researchers to demonstrate that the new PRO 
instrument is understandable to potential respondents. 
 Cognitive interviewing can minimize errors arising from respondents’ 
misunderstanding during data collection by assessing clarity of terminology, phrasing 
and format and is considered most valuable in pretesting complex questions and where 
questions might be sensitive and intrusive.42 Individual interviews are used within the 
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target population using techniques such as think aloud and /or verbal probing to 
ascertain exactly how an item is interpreted and how a response is formed.7 Semi-
structured interviews are recommended method for developing QoL questionnaires 
where lay people are involved.45 Cognitive interviews are audio recorded and 
transcribed verbatim and results are presentment in summary of essential findings, 
including representative quotations for each item or concept tested.7  
 Interview data serves to assist researchers in identifying problematic questions 
that may elicit response error and verify the relevance of item content to the target 
population.41,42 Findings from these interviews are reviewed and interpreted by the 
researcher, and modification/revisions are incorporated into the instrument.41 Key 
findings show whether items or scales on the questionnaire deviate from what is 
expected by the survey developers, or identify items, response scales, or instructions 
requiring modification. The revised instrument is often tested in further rounds until 
data saturation is achieved.41  
 Addressing all concerns and suggestions made by every participant is not 
possible, however demonstration that the new PRO instrument is understandable to 
potential respondents is essential in evaluation of content validity.7 It is important to 
recognize that data collected from cognitive interviews are qualitative in nature, and 
are mainly used to assess and improve questionnaire items before the questionnaire is 
implemented.42 Cognitive interviewing requires a level of understanding of patient 
issues alongside the ability to listen, interpret, and accurately report patient comments; 
all of which are not reflected in quantitative research.46 
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 Cognitive interviews have been used in several areas in health care research to 
pretest and validate questionnaire and to ensure high response rates and can be highly 
effective in developing questionnaires.42 Generally, small numbers of patients are 
selected, usually between 5 and fifteen, to complete a round of interviewing. 
6,41,46,47,48,49 Baxter et al.4 used a cognitive debriefing questionnaire asking patients 
eight generic questions to identify general content validity issues with the HPN-
QOL. Patients were asked if they thought any of the questions were irrelevant, or 
problematic. Researchers collaborated with patients in the development of the 
Rheumatoid Arthritis fatigue PRO questionnaire by using qualitative interview data to 
strengthen face and content validity of a draft conceptual framework. In this process, 
the researchers ensured comprehension of the PRO by the target population.49 
Schildmann et al.50 used cognitive interviewing in the first phase of a validation study 
of the Integrated Palliative care Outcome Scale, which proved to be valuable to 
increase content validity of the questionnaire. Additionally, in the development and 
validation of a new PRO for patients with pressure ulcers, cognitive interviews were 
used to identify problems with item content (i.e. ambiguous or confusing).51 
 It must be noted that cognitive interviews have been criticized for being overly 
subjective and artificial.42 However, rigor in qualitative research can be accomplished 
by having a “sound scientific methodology” and protocol, which includes semi-
structured interview scripts, appropriate analysis of the data and documentation of the 
findings.46   
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The Content Validity Index 
 Instrument content validity is often established through qualitative review 
alongside quantitative analysis of reviewer agreements.52 The use of quantitative data 
in the absence of thorough collection of knowledge, frameworks, and qualitative 
considerations can lead to a theoretical instrumentation producing scores with 
unknown meaning. It also should be recognized that the use of qualitative data alone 
to substantiate an instrument may be rhetorically convincing, but scientifically 
incomplete.7  
 In reports of instrument development, the most widely reported approach for 
content validity is the Content Validity Index (CVI).53,54 According to Polit et al.55, the 
CVI is the most widely used method of quantifying content validity for multiple item 
scales among nurse researchers.  
 The CVI is based on expert ratings of relevance, and is used for quantifying 
content validity for scales.55 A CVI value can be computed for each item on a scale (I-
CVI) as well as for the overall scale content validity average (S-CVI/AVG).55 The I-
CVI is calculated by having experts in the field of interest rate the relevance of each 
item to its own subdomain.56 A 4-point ordinal scale is used and expert panel members 
are asked to rate the item’s relevance to the construct of interest (i.e. 1:not relevant, 
2:somewhat relevant, 3:quite relevant, and 4:hightly relevant). The number of those 
judging the item as relevant (rating of 3 or 4), are divided by the number of experts on 
the panel.57 Although the CVI is used to determine content validity, this index does 
not consider the chance agreement. Wynd et al.52  proposed using both the multi-rater 
kappa statistic alongside the CVI to account for chance agreements.  
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 Calculating the S-CVI/AVG is done by first computing the I-CVI for each item on the 
scale and then by calculating the average I-CVI across items.55  
 In the development and content validation of an instrument measuring patient-
centered communication, fourteen designated experts completed the CVI using a 
modified kappa statistic to quantify item relevance.58 In this study, the researchers 
used a CVI criteria of .70 for item retention; resulting in the removal of 4 items from 
their prototype questionnaire as the result of this method. In a smaller sample (n=9), 
Larsson et al.59 used the CVI in the validation of muscle endurance questionnaire 
using a I-CVI score of ≥.78 to indicate “excellent” relevance; resulting in the deletion 
of fourteen items. To determine the content validity of The Osteoporosis Risk 
Assessment Tool (ORAT), eight experts were selected from nationally known 
clinicians and researchers holding well-respected reputations in the area of 
osteoporosis risk prevention and treatment.60 This study used an acceptable level of 
relevance score of .58 to determine item relevance and criteria for the deletion or 
retention of items on a draft questionnaire.60 Overall, the CVI is valuable to 
researchers because of its simplicity and its ability to provide information about each 
item, which then can be used for modification or deletion of instrument items.55,57  
 Once content validity is established and is ready for pilot testing, respondent 
burden should be assessed for undue physical, emotional, or cognitive strain. The time 
to complete the questionnaire should be adequate and efficient.18  
Psychometric Validation  
 As a final stage in instrument development, PRO measurement properties 
should be assessed for reliability (test-re-test), validity, ability to detect change, and 
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the interpretability (e.g. minimum important difference).18 Any indication for 
modification to the instrument following these steps should be addressed.18 
 Translation of PROMs into other languages should also be completed in the 
development process of all PRO questionnaires. This involves establishing conceptual 
and semantic equivalence and should include forward and backward translation 
methods, plus an assessment of the translated questionnaire’s measurement 
properties.61 However,  most PROMs are not available in a variety of different 
languages because of the costly nature of such a project. 61 This is problematic in 
healthcare settings because diverse cultures and language preferences are prevalent. 
Having a relative or friend to translate the questionnaire for the patient is not 
acceptable, as maintaining the correct meaning in the exchange cannot be 
guaranteed.61 
PRO’s in Clinical Practice 
 The use of PRO measures might seem quite straightforward; however, a 
number of pitfalls await clinicians with limited expertise. Defining the different 
applications of PRO instruments in clinical practice is difficult because of its complex 
nature and the heterogeneous methodology across PRO studies. These studies differ in 
what type of PRO they use, how the information is fed back, and whom it is fed back 
to.26 However, it is known that PRO instruments can enhance patient–clinician 
communication and inform plans of care to better target interventions that will 
improve patient outcomes.30, 31 Evidence supporting positive associations between 
physician communication behaviors and positive patient outcomes is strong. Such 
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outcomes include: patient ability to recall information, increase in patient 
understanding, and patient adherence to therapy.  
 There is also consensus on what constitutes “best practice” for physician 
communication in medical encounters (i.e. fostering the relationship, gathering 
information, providing information, making decisions, responding to emotions, and 
enabling disease-and treatment-related behavior).62 This is especially important as 
patients and doctors do not always agree on which outcomes of care are most 
significant. For example,  patients with multiple sclerosis, and possibly those with 
other chronic diseases, reported being less concerned than their clinicians about 
physical disability and are more concerned with issues impacting their QoL.63  
 According to Dawsons et al.61, there are very few published examples of the 
application of PRO’s in the context of clinical practice and quality assurance, and little 
evidence of the impact of using PRO’s in routine practice is lacking. Because there are 
a number of relevant questionnaires to choose from, clinicians can be challenged with 
determining the appropriate questionnaire for their intended purpose.  Alternatively, 
some questionnaires may seem entirely inappropriate and may contain items that are 
irrelevant to the target population. For this reason, the development of a treatment and 
disease specific PRO instruments is an important in fostering a increase in the use of 
PRO’s in clinical practice.  
 Evidence from randomized controlled trials suggests that the use of PROs in 
clinical practice is valuable in improving the discussion and detection of QoL 
constructs, but has less of an impact on how clinicians manage patient problems or on 
subsequent patient outcomes.26 Many of the reasons for this may lie in the ways in 
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which PROs fit (or do not fit) into the routine ways in which patients and clinicians 
communicate with each other, how clinicians make decisions, and how healthcare is 
organized. Greenhalgh et al. 26 suggests future research should seek to identify ways in 
which PROs can be better incorporated into the routine care of patients by combining 
qualitative and quantitative methods.  
 Regardless, use PRO instruments can provide several advantages; as a means 
to alert the clinician to the patient’s concerns about their QoL, to clarify via discussion 
the patient’s priorities for care, and to facilitate conversation between patients and 
clinicians about these issues.3 These positive outcomes and processes in patient care 
could lead to increased patient satisfaction.64 Use of PRO’s in clinical practice could 
also increase patient satisfaction by promoting patient-centered care. Domains used to 
assess patient satisfaction with care includes “communication and relationships”, and 
PRO instruments serve to foster improved communication between the patient and the 
clinician.65 In conclusion, this literature review supports the development of a PRO 
questionnaire for the HPN population could have a positive impact on patient-clinician 
communication, patient care and satisfaction, and overall quality of life.48 
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 Appendix B: Draft HPN-PROQ  
 
Home Parenteral Nutrition Patient Reported Outcomes Questionnaire  
(HPN-PRO-Q) 
 
 
Patient Instructions:   
This questionnaire is intended to help you identify areas of concern or problems with 
your home TPN over the last 2 weeks that may affect your quality of life and/or your 
ability to do the things you would like to do. These patient-reported outcomes (PRO) 
may be used to prioritize what you would like to discuss with your physician, health 
care professional, or members of your home parenteral nutrition management team as 
well as set goals for your care. 
 
Healthcare Professional Instructions:  The responses on this questionnaire are 
intended to facilitate discussion between patient and practitioner regarding patient 
goals related to home TPN and lifestyle adaptation. 
 
TPN = total parenteral nutrition 
 
During the past 2 weeks, how often have 
you experienced any of the following 
situations? 
Not at 
all 
Two to 
three 
days 
per 
week 
More 
than 
half 
of 
days 
Nearly 
every day 
1 I eat and enjoy the foods I want to eat.     
2 I can participate comfortably in social 
situations where food is served. 
    
3 Eating causes me to have gas or feel 
bloated. 
    
4 Eating causes me to have pain.     
5 I am able to live what I consider a 
normal lifestyle. 
    
6 I feel emotionally supported by my 
family and friends. 
    
7 I feel like my medical condition 
controls my life. 
    
8 Being on TPN is difficult to cope with.     
9 My TPN schedule limits my freedom 
to participate in daily activities. 
    
10 Carrying my TPN solution limits what 
I can do. 
    
11 I am confident with my ability to 
perform TPN procedures on my own. 
    
12 I feel physically strong.     
13 I am able to take care of myself.     
 61 
 14 I am able to participate in the activities 
I enjoy. 
    
15 I am able to walk without difficulty.     
16 I am able to climb up and down stairs 
without difficulty. 
    
17 I am able to rise from a chair or bed 
without difficulty. 
    
18 I am able to pick up an object from the 
floor without difficulty. 
    
19 I need to nap when I feel tired.     
20 I have enough strength and stamina to 
do daily chores or work. 
    
21 I am satisfied with the amount I sleep 
at night. 
    
22 The TPN pump disrupts my sleep.      
23 My sleep is disrupted because I have to 
get up to move my bowels or change 
my ostomy appliance. 
    
24 My sleep is disrupted because I have to 
get up to urinate. 
    
 
***Please answer these questions if you DO NOT have an end-jejunostomy or 
ileostomy BUT DO HAVE bowel in continuity. *** 
 
During the past 2 weeks, how often have 
you experienced any of the following 
situations? 
Not at 
all 
Two to 
three 
days per 
week 
More 
than 
half of 
days 
Nearly 
every 
day 
25 I move my bowels many times during 
the day. 
    
26 I move my bowels many times during 
the night. 
    
27 I have to move my bowels urgently.     
28 I have episodes of uncontrollable 
diarrhea. 
    
29 I have to move my bowels as soon as I 
eat food. 
    
30 I plan my daily activities around how 
much diarrhea I have. 
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 ***Please answer these questions if you DO HAVE an end-jejunostomy or ileostomy.  
 
During the past 2 weeks, how often have 
you experienced any of the following 
situations? 
Not at 
all 
Two to 
three 
days per 
week 
More 
than 
half of 
days 
Nearly 
every 
day 
31 I empty my ostomy appliance many 
times during the day. 
    
32 I empty my ostomy appliance many 
times during the night. 
    
33 I have to empty my ostomy appliance 
urgently. 
    
34 I have episodes of uncontrollable 
ostomy leakage. 
    
35 I have to empty my ostomy appliance 
as soon as I eat food. 
    
36 I plan my daily activities around how 
much ostomy output I have. 
    
 
How TRUE or FALSE is each of 
the following statements for you? 
Definitely 
True 
Mostly 
True 
Mostly 
False 
Definitely 
False 
1 Good quality of life means 
being able to do what I want 
to do when I want to do it. 
    
2 Having one or more nights 
without TPN is important to 
me. 
    
3 Having a shorter TPN 
infusion schedule is 
important to me. 
    
4 I feel relieved knowing my 
nutritional needs are being 
met by TPN. 
    
5 I do not need to eat because I 
receive TPN. 
    
6 I am fearful of developing 
complications related to my 
catheter. 
    
7 I am fearful of developing 
complications related to TPN. 
    
8 I understand the need for 
being on TPN. 
    
9 I am informed and well 
trained about managing my 
TPN. 
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 10 I am informed and well 
trained about the care of my 
catheter. 
    
11 I am informed and well 
trained about using my pump. 
    
12 I am informed and well 
trained about signs and 
symptoms of infection. 
    
13 I am informed and well 
trained about signs and 
symptoms of dehydration. 
    
14 I understand my diet and 
what I should be eating. 
    
15 I know whom to call when I 
have questions about my 
TPN. 
    
16 I feel well supported by my 
home care specialists. 
    
17 I received information about 
local or national support 
groups for TPN. 
    
18 I wish I knew more about my 
TPN. 
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 Appendix C: Final HPN-PROQ 
 
 
Home Parenteral Nutrition Patient Reported Outcomes Questionnaire 
 
 
Patient Instructions:   
This questionnaire is intended to help you identify areas of concern or problems with 
your home TPN over the last 2 weeks that may affect your quality of life and/or your 
ability to do the things you would like to do. These patient-reported outcomes (PRO) 
may be used to prioritize what you would like to discuss with your physician, health 
care professional, or members of your home parenteral nutrition management team as 
well as set goals for your care. 
 
Healthcare Professional Instructions:  The responses on this questionnaire are 
intended to facilitate discussion between patient and practitioner regarding patient 
goals related to home TPN and lifestyle adaptation. 
 
“TPN” = total parenteral nutrition solution/formula. 
“TPN therapy” = procedures/equipment/devices necessary to administer the TPN 
solution/formula 
 
 
HPN Consumers: Please place a “X” on the dotted line where it most clearly indicates 
the frequency of occurrence for each of the given situations over the past two weeks. 
 
 
 During the past 2 weeks, please estimate how often you experienced any of the 
following situations. 
1. I felt like my health limited the things I want to do in my life. 
 Not at all ----------------------------------------|-------------------------------------- Every day 
2.  Being on TPN was difficult to cope with emotionally. 
 Not at all ----------------------------------------|-------------------------------------- Every day 
 - Please continue to the next page - 
HPN-PROQ 
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During the past 2 weeks, please estimate how often you experienced any of the 
following situations. 
3.  My daily activities were limited by my TPN infusion schedule. 
 Not at all ----------------------------------------|-------------------------------------- Every day 
4. I was able to participate in the activities I enjoy. 
 Not at all ----------------------------------------|-------------------------------------- Every day 
5. I was able to walk without difficulty. 
 Not at all ----------------------------------------|-------------------------------------- Every day 
6. I was able to rise from a chair or bed without difficulty. 
 Not at all ----------------------------------------|-------------------------------------- Every day 
7. I had enough strength and stamina to do daily chores or work. 
 Not at all ----------------------------------------|-------------------------------------- Every day 
8. The TPN pump disrupted my sleep.  
 Not at all ----------------------------------------|-------------------------------------- Every day 
9. My sleep was disrupted because I had to get up to move my bowels or empty my ostomy bag. 
 Not at all ----------------------------------------|-------------------------------------- Every day 
10.  My sleep was disrupted because I had to get up to urinate. 
 Not at all ----------------------------------------|-------------------------------------- Every day 
11. I ate comfortably in social situations and around others. 
 Not at all ----------------------------------------|-------------------------------------- Every day 
 - Please continue to the next page - 
 66 
  
 
***Answer questions 12 &13 if you do NOT have an end-jejunostomy or ileostomy 
but do have bowel in continuity. *** 
 
12. I had episodes of uncontrollable diarrhea. 
 Not at all ----------------------------------------|-------------------------------------- Every day 
13.  I had to rearrange my daily plans because of how much diarrhea I had. 
 Not at all ----------------------------------------|-------------------------------------- Every day 
  
 ***Answer questions 14-16 if you HAVE an end-jejunostomy or ileostomy. *** 
 During the past 2 weeks, please estimate how often you experienced any of the following situations. 
14. I had episodes of uncontrollable ostomy leakage. 
 Not at all ----------------------------------------|-------------------------------------- Every day 
15.  I had to empty my ostomy bag shortly after I ate food. 
 Not at all ----------------------------------------|-------------------------------------- Every day 
16.  I had to rearrange my daily plans because of how much ostomy output I had. 
 Not at all ----------------------------------------|-------------------------------------- Every day 
 - Please continue to the next page - 
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  How TRUE or FALSE are the following statements to you? 
1. Good quality of life means being able to do what I want to do when I want to do it. 
 Definitely false ----------------------------------|------------------------------- Definitely true 
2. I eat and enjoy the foods I want to eat. 
 Definitely false ----------------------------------|------------------------------- Definitely true 
3. I am confident in my ability to perform TPN procedures on my own. 
 Definitely false ----------------------------------|------------------------------- Definitely true 
4.  Having one or more nights or days without TPN is important to me. 
 Definitely false ----------------------------------|------------------------------- Definitely true 
5. Having a shorter TPN infusion schedule is important to me. 
 Definitely false ----------------------------------|------------------------------- Definitely true 
6.  I feel relieved knowing my nutritional needs are being met by TPN therapy. 
 Definitely false ----------------------------------|------------------------------- Definitely true 
7.  I am fearful of developing complications related to my TPN therapy and/or central line. 
 Definitely false ----------------------------------|------------------------------- Definitely true 
8.  I understand my need for being on TPN therapy. 
 Definitely false ----------------------------------|------------------------------- Definitely true 
9.  I know and have been trained on how to manage my TPN therapy. 
 Definitely false ----------------------------------|------------------------------- Definitely true 
 - Please continue to the next page - 
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  How TRUE or FALSE are the following statements to you? 
10.  I know and have been trained on how to care for my central line. 
 Definitely false ----------------------------------|------------------------------- Definitely true 
11. I know and have been trained on how to use my pump. 
 Definitely false ----------------------------------|------------------------------- Definitely true 
12. I know and have been trained on the signs and symptoms of a central line infection. 
 Definitely false ----------------------------------|------------------------------- Definitely true 
13.  I know and have been trained on the signs and symptoms of dehydration. 
 Definitely false ----------------------------------|------------------------------- Definitely true 
14. I know and have been trained about my diet and what I should be eating. 
 Definitely false ----------------------------------|------------------------------- Definitely true 
15. I know whom to call when I have questions about my TPN therapy. 
 Definitely false ----------------------------------|------------------------------- Definitely true 
16. I feel emotionally supported by my family and friends. 
 Definitely false ----------------------------------|------------------------------- Definitely true 
17. I feel well supported by my home care specialists. 
 Definitely false ----------------------------------|------------------------------- Definitely true 
 
18. I received information about local or national support groups for TPN therapy. 
 Definitely false ----------------------------------|------------------------------- Definitely true 
 - Please continue to the next page - 
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  How TRUE or FALSE are the following statements to you? 
19. I wish I knew more about my TPN therapy. 
 Definitely false ----------------------------------|------------------------------- Definitely true 
 
 
 
 
Thank you for completing the  
Home Parenteral Nutrition Patient Reported Outcomes Questionnaire  
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 Appendix E: Recruitment Materials 
 
Flyer for Oley Foundation Website/Newsletter/Email 
 
Volunteers Wanted for Research Study 
To participate in the development of a new questionnaire created to serve the 
Home Parenteral Nutrition (HPN) Population. 
 
This is a URI research study, the principle investigator is Dr. Geoffrey Greene. The 
purpose of this study is to assess the content validity of the Home Parenteral Nutrition 
Patient Reported Outcome Questionnaire (HPN-PRO-Q). This questionnaire is 
intended to be used in clinical practice by patients to self-assess factors that influence 
quality of life or adaptation to HPN. We intend to evaluate a questionnaire about HPN 
and quality of life that may be used in the future to start a conversation about your 
quality of life with your doctor or HPN management team.  
You will be asked to participate in a interview via telephone so that we may assess 
your individual understanding and comprehension of the questions included on the 
HPN-PRO-Q. The interviewer will be located in be in a private office located at the 
University of Rhode Island Kingston, RI- Fogerty Hall, office 103. The interview 
should take about one hour or longer, depending on how much you want to speak 
about each item on the questionnaire. Our conversation will be kept completely 
confidential and your responses will remain confidential.  
There is no direct benefit to you. It is hoped that the information from the interview 
will lead to a better understanding of the relevance, comprehension, and 
appropriateness of each question in the HPN-PRO-Q. 
 
This research has been approved by the University of Rhode Island (URI) Institutional 
Review Board (IRB).  
 
To be eligible you must: 
• Receive home parenteral nutrition. 
• Be willing to speak about your experiences living with home parenteral 
nutrition. 
• Be over 18 years-old. 
• Live in the United States 
• Have computer access, an active email address, access to the internet, and a 
telephone you can access while simultaneously using your computer. 
• Be English speaking. 
 
Confidentiality of all information will be maintained. This study will take place from 
June-November 2016.  
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For more information or to indicate your interest in participating in the study, email 
Tracy Miller at HPN-PRO@etal.uri.edu. Please include your name, telephone number 
with area code, email address, and best time to reach you. 
 
 
Thank you for considering to participate in this research study! 
The University of Rhode Island 
Department of: Department of Nutrition and Food Sciences 
Content Validity of Home Parenteral Nutrition Patient Reported Outcome 
Questionnaire 
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Expert Panel I-CVI, S-CVI Recruitment Letter/Email 
 
Volunteers Wanted for Research Study 
To participate in the development of a new questionnaire created to serve the 
Home Parenteral Nutrition Population 
 
We are looking for the following persons: 
• Home parenteral nutrition clinicians, physicians, nurses 
• Homecare advocates 
• Registered dietitians 
 
This is a URI research study; the principle investigator is Dr. Geoffrey Greene. The 
purpose of this study is to assess the content validity of the Home Parenteral Nutrition 
Patient Reported Outcome Questionnaire (HPN-PRO-Q). This questionnaire is 
intended to be used in clinical practice by patients to self-assess factors that influence 
quality of life or adaptation to HPN. This assessment is meant to facilitate a 
conversation between health-care providers, the patient, and other members of the 
home nutrition care team. This research is being conducted in collaboration with 
Marion Winkler, PhD, RD, LDN, CNSC.  
 
We are looking for experts in the field of HPN. If you are a HPN clinician, 
physician, homecare advocate, nurses, and/or a dietitian you are eligible to 
participate in this study. We are looking for your feedback on the HPN-PRO-Q, as it is 
valuable in the development of this instrument.  
 
We will be asking you to complete the Content Validity Index (CVI). The item-
level Content Validity Index (I-CVI) is calculated by having experts in the field of 
interest rate the relevance of each item to its own subdomain. The item-level Content 
Validity Index (I-CVI) is calculated by having the experts rate the relevance of each 
item to its own subdomain. (1=not relevant, 2=somewhat relevant, 3=quite relevant, 
4=highly relevant.) 
 
If you agree to participate, you will be sent a CVI-Worksheet via email. Upon 
completion of the worksheet, you will be asked to save your work as a PDF and return 
it to the research email address.  
This process should take approximately 20 minutes. Pending your availability, you 
may be asked to complete an additional round of the I-CVI after revisions to the 
instrument are made. This process should take an approximately and additional 20 
minutes.  
 
Confidentiality of all all information will be maintained. This research has been 
approved by the University of Rhode Island’s (URI) Institutional Review Board 
(IRB).  
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There is no direct benefit to you for participating in the study. It is hoped that the 
information you provide will lead to a better understanding of the relevance of the 
items included on the HPN-PRO-Q.  
For more information or to indicate your interest in participating in the study, email 
Tracy Miller at HPN-PRO@etal.uri.edu. Please include your name, telephone number 
with area code, email address, and best time to reach you.  
 
Thank you for considering to participate in this research study. 
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HPN Patient-Cognitive Interview Screener Email 
 
Dear Mr. or Ms._________, 
 
Thank you for your interest in this study. This is a URI research study, the principle 
investigator is Dr. Geoffrey Greene. The purpose of this study is to assess the content 
validity of the Home Parenteral Nutrition Patient Reported Outcome Questionnaire 
(HPN-PRO-Q). This questionnaire is intended to be used in clinical practice by 
patients to self-assess factors that influence quality of life or adaptation to HPN. There 
is no direct benefit to you. It is hoped that the information from the interview will lead 
to a better understanding of the relevance, comprehension, and appropriateness of each 
question in the HPN-PRO-Q.  
 
This research has been approved by the University of Rhode Island (URI) Institutional 
Review Board (IRB).  
 
In order to determine if you are eligible to participate, please answer the following 
questions and return by email within the next 3 days.  If you have any questions, 
please contact the research team @ HPN-PRO@etal.uri.edu.   
 
Criteria for Participation 
 Do you live in the US? 
What is your age in years? 
Are you pregnant? 
Are you receiving home TPN? 
Do you speak English? 
Do you have computer access? 
Can you talk on the telephone and read on the computer at the same time?  
 
You will be asked to participate in a 60-90 minute interview via telephone so that we 
may assess your individual understanding and comprehension of the questions 
included on the HPN-PRO-Q. The interviewer will be located in be in a private office 
located at the University of Rhode Island Kingston, RI- Fogerty Hall, office 103.  
 
Please send responses to HPN-PRO@etal.uri.edu 
You will be hearing from me by [Date] 
Thank you and I am looking forward to working with you! 
 
 
Sincerely, 
Tracy-Lee Miller,  
Graduate Student in Food Science and Nutrition 
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Introduction 
Hello,  
My name is Tracy. I am a graduate student at the University of Rhode Island. Thank 
you for participating in this study. The purpose of this study is to evaluate a 
questionnaire about HPN and quality of life that may be used in the future to start a 
conversation about your quality of life with your doctor or HPN management team.  
This questionnaire is called the Home Parenteral Nutrition Patient Reported Outcomes 
Questionnaire (HPN-PRO-Q) for short.  I appreciate the time you’ve set aside to speak 
with me about your experiences on home parenteral nutrition and living with nutrition 
support.  
 
Before we begin, I want to review a few things with you.  
 
Your participation in this interview is completely voluntary; you may choose not to 
participate.  
 
If there are any questions you do not wish to answer, just let me know and we can skip 
it.  
 
You can stop the interview at any time.  
 
The interview should take about one hour or longer, depending on how much you 
want to speak about each item on the questionnaire. Our conversation will be kept 
completely confidential and your responses will remain anonymous.  
I am in a private office and will be using a speakerphone. No one else will be in the 
room with me. 
 
If you agree, our conversation will be tape-recorded in order to document your exact 
words. The tapes will be destroyed at the end of this project. The transcripts will be 
numbered and will not contain your name or any identifying information.  
 
There is no risk to you by answering these questions. There is no direct benefit to you. 
It is hoped that the information from the interview will lead to a better understanding 
of the relevance, comprehension, and appropriateness of each question in the HPN-
PRO-Q.  
 
Your comments will be combined with other study patients when the results are 
analyzed. Nothing you tell me will be presented or published in a way that someone 
could identify you.  
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Do you have any questions about the information we discussed? 
I will be turning the tape recorder on now. Do I have permission to tape this 
conversation? 
 
--This interview should take about 1 hour. Please let me know if you need to take a 
break, would like to end the interview, or prefer to skip a question.  
 
 
The first couple of questions are about your TPN. 
 What is your diagnosis relating to your need for home TPN? 
 How long have you been receiving home parenteral nutrition? 
 What is your number of home TPN infusion days/hours per week? 
 
 
Now, I am going to read you 30 statements and ask you what the statement means to 
you.  I may ask you to repeat the statement in your own words.  I may ask you what a 
specific term or word means to you. All of the statements will ask you to recall how 
often you experienced the symptom or feeling in the past 2 weeks. I may ask you how 
you remember that you felt that way. 
 
The first questions I am going to ask you are about how often something or an 
event happens to you in a 2-week period. 
 
In a 2 week time frame, what does the response "not at all" mean to you? 
 
In a 2 week time frame, what does the response "2-3 days per week " mean to you? 
 
In a 2 week time frame, what does the response "" more than half the day mean to 
you? 
 
In a 2-week time frame, what does the response "nearly every day" mean to you? 
 
The next few questions are about eating.  Tell me what you are thinking when I 
read the statement to you: 
 
I eat and enjoy the foods I want to eat. 
Please repeat the statement I just read to you in your own words. 
Would this be easy or hard to answer? 
What does "eat" mean to you? 
What does "enjoy foods" mean to you? 
Would you be able to remember how many times you enjoyed eating food in the past 
2 weeks? 
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How do you remember how often you experienced enjoying the foods you want to eat 
in the past 2 weeks? 
  
I can participate comfortably in social situations where food is served. 
 Please repeat the statement I just read to you in your own words. 
 Would this be easy or hard to answer?   
 What does "social situation" mean to you? 
 What does "around others" mean to you? 
 Would you be able to remember how many times you comfortably ate in social 
 situations or around others in the past 2 weeks? 
 How do you remember how often you experienced you comfortably ate in 
 social situations or around others in the past 2 weeks? 
  
Eating causes me to have gas or feel bloated? 
 Please repeat the statement I just read to you in your own words. 
 Would this be easy or hard to answer?   
 What does "gas" mean to you? 
 What does "bloated" mean to you? 
 Would you be able to remember how many times eating caused gas or made 
 you bloated in the past 2 weeks? 
 How do you remember how often you experienced gas or felt bloated in the 
 past 2  weeks? 
 
Eating causes me to have pain? 
 Please repeat the statement I just read to you in your own words. 
 Would this be easy or hard to answer?   
 What does "pain" mean to you? 
 Would you be able to remember how many times eating caused pain in the past 
 2 weeks? 
 How do you remember how often you experienced had pain while eating in the 
 past 2 weeks? 
 
The next few questions are about your lifestyle. Tell me what you are thinking 
when I read the statement to you: 
 
I am able to live what I consider a normal lifestyle. 
 Please repeat this statement in your own words. 
 Would this be easy or hard to answer?   
 What does the term "normal lifestyle" mean to you? 
 Would you be able to answer how often in the last 2 weeks you were able to 
 live a  normal lifestyle? 
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I feel emotionally supported by my family and friends. 
 Please repeat this statement in your own words. 
 Would this be easy or hard to answer?   
 Who are you referring to when I ask about feeling emotionally supported by 
 “family”? 
 Who are you referring to when I ask about “friends” emotionally supporting 
you? 
 
 
I feel like my medical condition controls my life. 
 Please repeat this statement in your own words? 
 Would this be easy or hard to answer?   
 What does the term "medical condition" mean to you? 
 What does the concept "control your life” mean to you? 
 Would you be able to remember how many times you felt controlled by your 
 medical condition in the past two weeks? 
  
 
The next few questions are about your TPN or [patients name for nutrition 
therapy].  
 
Tell me what you are thinking when I read the statement to you: 
  
Being on TPN [or patient’s name for nutrition therapy] is difficult to cope with. 
 Please repeat this statement in your own words. 
 Would this be easy or hard to answer?   
 What does the term "cope" mean to you? 
 Would you be able to remember how many times in the past 2 weeks TPN was 
 difficult to cope with? 
  
My TPN schedule limits my freedom to participate in daily activities? 
 Please repeat this statement in your own words. 
 Would this be easy or hard to answer?   
 What does “TPN schedule” mean to you?  
 What does “limit my freedom” mean to you? 
 What does “daily activities” mean to you? 
 Would you be able to remember how many times your TPN schedule limited 
 your daily activates in the past 2 weeks? 
  
Carrying the TPN solution limits what I can do. 
 Please repeat this statement in your own words. 
 Would this be easy or hard to answer?  
 What does the term “TPN solution” mean to you? 
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 What does “limits” mean to you? 
 Would you be able to remember how many times carrying your TPN solution 
 limited what you wanted to do in the past 2 weeks? 
 
I am confident with my ability to perform TPN procedures on my own? 
 Please repeat this statement in your own words. 
 Would this be easy or hard to answer?   
 What does it mean to you to be "confident"? 
 What does "perform TPN procedures" mean to you? 
 What TPN procedures do you perform by yourself? 
 Would you be able to remember how many times you performed TPN 
procedures by  yourself in the past 2 weeks? 
  
The next questions are about your energy level and strength. Tell me what you 
are thinking when I read the statement to you: 
 
I feel physically strong. 
 Please repeat this statement in your own words. 
 Would this be easy or hard to answer   
 What does it mean to you to be "physically strong"? 
 Would you be able to remember how many times you felt physically strong in 
the    past 2 weeks? 
 
 I am able to take care of myself. 
 Please repeat this statement in your own words. 
 Would this be easy or hard to answer? 
 What does "able to take care of yourself" mean to you?   
 Would you be able to remember how many times you were able to take care of 
   yourself in the past 2 weeks? 
   
I am able to participate in the activities I enjoy. 
 Please repeat this statement in your own words. 
 Would this be easy or hard to answer? 
 What “activities” would you be referring to if you were answering this 
question? 
 Would you be able to remember how many times you were able to enjoy the 
   activities you listed above in the past 2 weeks? 
 
I am able to walk without difficulty. 
 Please repeat this statement in your own words. 
 Would this be easy or hard to answer? 
 What does “without difficulty” mean to you? 
 Would you be able to remember how many times you were able to walk  
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without difficulty in the past 2 weeks? 
 
I am able to climb up and down stairs without difficulty. 
 Please repeat this statement in your own words. 
 Would this be easy or hard to answer? 
 Do you have stairs you need to climb in your home?  
 What does “without difficulty” mean to you? 
 Would you be able to remember how many times you climbed the stairs 
without    difficulty in the past 2 weeks? 
 
I am able to rise from a chair or bed without difficulty. 
 Please repeat this statement in your own words. 
 Would this be easy or hard to answer? 
 What does “rise without difficulty” mean to you? 
 Would you be able to remember how many times in you got out of bed or chair 
 without difficulty the past 2 weeks? 
   
I am able to pick up an object from the floor without difficulty. 
 Please repeat this statement in your own words. 
 Would this be easy or hard to answer? 
 What does the term “object” mean to you? 
 What does without difficulty” mean to you? 
 Would you be able to remember how many times you were able to pick up a 
 object from the floor in the past 2 weeks? 
   
I need to nap when I feel tired. 
 Please repeat this statement in your own words. 
 Would this be easy or hard to answer? 
 What does “nap” mean to you? 
 What does “feel tired” mean to you? 
 Would you be able to remember how many times you napped in the past 2 
 weeks? 
   
I have enough strength and stamina to do daily chores or work. 
 Please repeat this statement in your own words. 
 Would this be easy or hard to answer? 
 What does “enough” mean to you? 
 What does “strength” mean to you? 
 What does “stamina” mean to you? 
 What do “daily” chores mean to you? 
 Do you work? What do you do for work? 
 Would you be able to remember how many times you had enough stamina to 
 do daily chores or work in the past 2 weeks?  
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The next few questions are about sleeping. Tell me what you are thinking when I 
read the statement to you: 
 
I am satisfied with the amount I sleep at night. 
 Please repeat this statement in your own words. 
 Would this be easy or hard to answer? 
 What does “satisfied” mean to you? 
 How many hours do you sleep? 
 Would you be able to remember how many times you were satisfied with the 
 amount of time you slept in the past 2 weeks? 
 
The TPN pump disrupts my sleep. 
 Please repeat this statement in your own words. 
 Would this be easy or hard to answer? 
 What does “disrupts” mean to you? 
 In what way does your TPN pump disrupt your sleep? 
 Would you be able to remember how many times the pump disrupted your 
 sleep in the past 2 weeks? 
   
My sleep is disrupted because I have to get up to move my bowels or change my 
ostomy appliance. 
 Please repeat this statement in your own words, 
 Would this be easy or hard to answer? 
 What does “disrupted” mean to you? 
 Would you be able to remember how many times your sleep was disrupted 
 because of needing to move your bowels or empty your ostomy  appliance 
 in the past 2 weeks? 
     
My sleep is disrupted because I have to get up to urinate. 
 Please repeat this statement in your own words. 
 Would this be easy or hard to answer? 
 What does “urinate” mean to you? 
 What does “disrupted sleep” mean to you? 
 Would you be able to remember how many times your sleep was disrupted to 
 get up and urinate in the past 2 weeks?  
 
 
Before I ask you the next question, please tell me if you have an ostomy or if you 
go to the bathroom to move your bowels on the toilet?  
If YES,  
I move my bowels many times during the day. 
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Please repeat this statement in your own words. 
 Would this be easy or hard to answer? 
 What does “move my bowels” mean to you? 
 What does “many times a day” mean to you? 
 Would you be able to remember how many days you had to move your bowels 
 many times a day in the past 2 weeks? 
   
I move my bowels many times during the night. 
 Please repeat this statement in your own words. 
 Would this be easy or hard to answer? 
 What does “many times during the night” mean to you? 
 Would you be able to remember how many nights you had to move your 
 bowels throughout the night in the past 2 weeks? 
 
 I have to move my bowels urgently. 
 Please repeat this statement in your own words. 
 Would this be easy or hard to answer? 
 What does “urgently” mean to you? 
 Would you be able to remember how many days you had to move your bowels 
 urgently in the past 2 weeks?  
  
 I have episodes of uncontrollable diarrhea. 
 Please repeat this statement in your own words. 
 Would this be easy or hard to answer? 
 What does “uncontrollable diarrhea” mean to you? 
 Would you be able to remember how many episodes of uncontrollable diarrhea 
 you had in the past 2 weeks? 
 
 I have to move my bowels as soon as I eat food. 
 Please repeat this statement in your own words. 
 Would this be easy or hard to answer? 
 What does “as soon as you eat” mean to you? 
 Would you be able to remember how times you had to move your bowels as 
 soon as you ate in the past 2 weeks? 
 
 I plan my daily activities around how much diarrhea I have. 
 Please repeat this statement in your own words. 
 Would this be easy or hard to answer? 
 What does “daily activities” mean to you? 
 What does it mean to “plan around” your daily activities? 
 Would you be able to remember how many days you to had plan your daily 
 activities around how much diarrhea you have?  
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If NO,  
I empty my ostomy appliance many times during the day. 
 Please repeat this statement in your own words. 
 Would this be easy or hard to answer? 
 What does “many times” mean to you? 
 What does “empty my ostomy appliance” mean to you? 
 Would you be able to remember how many days you have to empty you 
 ostomy appliance many times a day in the past 2 weeks? 
 
I empty my ostomy appliance many times during the night. 
 Please repeat this statement in your own words. 
 Would this be easy or hard to answer? 
 What does “many times during the night” mean to you? 
 Would you be able to remember how many nights you had to empty your 
 ostomy appliance many times in the past 2 weeks? 
  
I have to empty my ostomy appliance urgently. 
 Please repeat this statement in your own words. 
 Would this be easy or hard to answer? 
 What does “urgently” mean to you? 
 Would you be able to remember how many times you had to urgently empty 
 your ostomy appliance in the past 2 weeks? 
 
I have episodes of uncontrollable ostomy leakage 
 Please repeat this statement in your own words. 
 Would this be easy or hard to answer? 
 What does “uncontrollable leakage” mean to you? 
 Would you be able to remember how many days you had uncontrollable 
 ostomy  leakage in the past 2 weeks? 
 
I have to empty my ostomy appliance as soon as I eat food. 
 Please repeat this statement in your own words. 
 Would this be easy or hard to answer? 
 What does “as soon as you eat” mean to you? 
 Would you be able to remember how many times you had to empty your 
 ostomy appliance as soon as you ate food in the past 2 weeks? 
 
I plan my daily activities around how much ostomy output I have. 
 Please repeat this statement in your own words. 
 Would this be easy or hard to answer? 
 What does “daily activities” mean to you? 
 What does “ostomy output” mean to you? 
 Would you be able to remember how many days you had to plan your daily 
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activities around how much ostomy output you have move in the past 2 weeks? 
 
 
True/False 
Good quality of life means being able to do what I want to do when I want to do it.
 Please repeat this statement in your own words. 
 Would this be easy or hard to answer? 
Having one or more nights without TPN is important to me. 
 Please repeat this statement in your own words. 
 Would this be easy or hard to answer? 
   
Having a shorter TPN infusion schedule is important to me. 
 Please repeat this statement in your own words. 
 Would this be easy or hard to answer? 
   
I feel relieved knowing my nutritional needs are being met by TPN. 
 Please repeat this statement in your own words. 
 Would this be easy or hard to answer? 
 What does the term “nutritional needs” mean to you? 
 What does it mean to “have your nutritional needs met”? 
 
I do not need to eat because I receive TPN. 
 Please repeat this statement in your own words. 
 Would this be easy or hard to answer? 
 What does “do not need to eat” mean to you? 
I am fearful of developing complications related to my catheter. 
 Please repeat this statement in your own words. 
 Would this be easy or hard to answer? 
 What does “complications related to my catheter” mean to you? 
 What does “fearful” mean to you? 
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I understand the need for being on TPN. 
 Please repeat this statement in your own words. 
 Would this be easy or hard to answer? 
 What does “need for being on TPN” mean to you? 
  
I am informed and well trained about managing my TPN. 
 Please repeat this statement in your own words. 
Would this be easy or hard to answer 
 What does “informed” mean to you? 
 What does “well-trained” mean to you? 
 What does “managing my TPN” mean to you? 
 
I am informed and well trained about the care of my catheter. 
 Please repeat this statement in your own words. 
 Would this be easy or hard to answer? 
 In this instance, what does “informed” mean to you? 
 What does “well-trained” mean to you? 
I am informed and well trained about using my pump. 
 Please repeat this statement in your own words. 
 Would this be easy or hard to answer? 
 In this instance, what does “informed” mean to you? 
 What does “well-trained to take care of my catheter” mean to you? 
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I am informed and well trained about signs and symptoms of infection. 
 Please repeat this statement in your own words. 
 Would this be easy or hard to answer? 
 What does “signs and symptoms of infection” mean to you? 
 In this instance, what does “informed” mean to you? 
 What does “using my pump” mean to you? 
 
I am informed and well trained about signs and symptoms of dehydration. 
 Please repeat this statement in your own words. 
 Would this be easy or hard to answer? 
 What does “signs and symptoms of dehydration” mean to you? 
 In this instance, what does “informed” mean to you? 
 What does “well-trained” mean to you? 
 
I understand my diet and what I should be eating. 
 Please repeat this statement in your own words. 
 Would this be easy or hard to answer? 
 What does “diet” mean to you? 
 What does “should be eating” mean to you? 
 What does it mean to “understand”?   
 
I know whom to call when I have questions about my TPN. 
 Please repeat this statement in your own words. 
 Would this be easy or hard to answer? 
 Who do you call when you have questions about your TPN? 
 Would you call that person if you had questions about your TPN? 
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What does it mean to have “questions about my TPN”? 
 
I feel well supported by my home care specialists. 
 Please repeat this statement in your own words. 
 Would this be easy or hard to answer? 
 What does “home care specialists” mean to you? 
 Do you have a “home care specialist?” 
 What does the concept of feeling well supported mean to you? 
I received information about local or national support groups for TPN. 
 Please repeat this statement in your own words. 
 Would this be easy or hard to answer? 
Appendix G: Oral Consent Script and Interview Guide 
What does “support group” mean to you? 
 Do you utilize local or national support groups? 
 If yes, which support group do you utilize? 
      
I wish I knew more about my TPN. 
 Please repeat this statement in your own words. 
 Would this be easy or hard to answer? 
 What does “know more” mean to you? 
 Do you know how to learn more about your TPN? 
 
Now, a few more questions are about you: 
What is your age in years? 
Are you male or female?   
 89 
 What is your highest level of education?  
How many people live in your household?  
Are you married, single, or divorced? 
Do you have a caregiver to help with TPN procedures, and if yes, who?  
What is your race? 
What is your ethnicity? 
 
 
Finally, I would like to get your personal impression on the HPN-PROQ. Do you think 
this may be useful during a visit the doctor, clinician, or other health-care professional 
who helps you manage your TPN?  
 
Thank you for participating in this study. If is okay with you, may I contact you at a 
future date to clarify some of the feedback you provided me with today? 
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 Thank you for agreeing to participate in this study. Research by Winkler et al. (2010) 
determined that patients in the Home Parenteral Nutrition (HPN) population perceived their 
routine medical appointments as a parenteral nutrition “tune-up,” with sessions focusing 
primarily on disease aspects of care. In addition to medical examination and nutrition 
assessment, HPN patients desired a more holistic approach to parenteral nutrition management 
incorporating both physical and emotional support. 
  Patient reported outcomes comprise information from patients about health 
conditions and management, making them a valuable tool to identify concerns and in 
facilitating communication around patients’ health-related quality of life. The Home 
Parenteral Nutrition Patient Reported Outcome Questionnaire (HPN-PROQ) is meant to be 
completed by adult home parenteral nutrition patients.  
 This is a University of Rhode Island research study; the principal investigator is Dr. 
Geoffrey Greene. The completion of this worksheet represents your informed consent and 
agreement to participate in this study. Your responses will remain confidential and results 
will not be published in a way that may identify you. 
 Attached to this cover letter is the Content Validity Index Worksheet. Instructions are 
included within the document. At your earliest convenience, please complete the worksheet, 
save as a PDF, and return it to HPNpatientoutcomes@etal.uri.edu by 2/10/17.  If you have 
any questions, please contact me via email.  
-This research is being conducted in collaboration with Marion Winkler, PhD, RD, LDN, 
CNSC-  
HPN-PROQ 
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of Science-Nutrition and Dietetics 
University of Rhode Island 
Expert Review: Content Validity Index 
 
Directions: Attached is the HPN-PROQ. Please rate each item on the Home 
Parenteral Nutrition Patient Reported Outcome Questionnaire (HPN-PRO-Q) based 
on its relevance to the HPN population. ** Please CHECK THE BOX next to the 
number that corresponds to your answer.  
 
1="Not Relevant", 2="Somewhat Relevant", 3="Quite Relevant", or 4="Highly 
Relevant". 
 
SEE EXAMPLES 1 & 2 EXPERT REVIEWERS: Please CHECK THE 
BOX next to the number that corresponds to your answer. PLEASE MAKE SURE 
YOU ONLY CHOOSE ONE BOX PER QUESTION. 
 
 
 
During the past 2 weeks, please estimate how often you have experienced 
any of the following situations. 
1. I felt like my health limited the things I want to do in my life. 
 Not at all -----------------------------------|--------------------------------- Every day 
Not Relevant 
1  
Somewhat Relevant 
2  
Quite Relevant 
3  
Highly Relevant 
4  
2.  Being on TPN was difficult to cope with emotionally. 
 Not at all --------------------------------------|--------------------------------- Every day 
Not Relevant 
1  
Somewhat Relevant 
2  
Quite Relevant 
3  
Highly Relevant 
4  
 - Please continue to the next page - 
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 Home Parenteral Nutrition Patient Reported Outcomes Questionnaire  
CVI WORKSHEET 
 
 
Patient Instructions:   
This questionnaire is intended to help you identify areas of concern or problems with 
your home TPN over the last 2 weeks that may affect your quality of life and/or your 
ability to do the things you would like to do. These patient-reported outcomes (PRO) 
may be used to prioritize what you would like to discuss with your physician, health 
care professional, or members of your home parenteral nutrition management team as 
well as set goals for your care. 
 
Healthcare Professional Instructions:  The responses on this questionnaire are 
intended to facilitate discussion between patient and practitioner regarding patient 
goals related to home TPN and lifestyle adaptation. 
“TPN” = total parenteral nutrition solution/formula. 
“TPN therapy” = procedures/equipment/devices necessary to administer the TPN 
solution/formula 
 
HPN Consumers: Please place a “X” on the dotted line where it most clearly 
indicates the frequency of occurrence for each of the given situations over the 
past two weeks. 
EXPERT REVIEWERS: Please CHECK THE BOX next to the number that 
corresponds to your answer. PLEASE MAKE SURE YOU ONLY CHOOSE ONE 
BOX PER QUESTION. 
 During the past 2 weeks, please estimate how often you experienced any of the 
following situations. 
1. I felt like my health limited the things I want to do in my life. 
 Not at all -----------------------------------|--------------------------------- Every day 
Not Relevant 
1  
Somewhat Relevant 
2  
Quite Relevant 
3  
Highly Relevant 
4  
2.  Being on TPN was difficult to cope with emotionally. 
 Not at all -----------------------------------|--------------------------------- Every day 
Not Relevant 
1  
Somewhat Relevant 
2  
Quite Relevant 
3  
Highly Relevant 
4  
 - Please continue to the next page -  
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During the past 2 weeks, please estimate how often you experienced any of the 
following situations. 
3.  My daily activities were limited by my TPN infusion schedule. 
 Not at all -----------------------------------|--------------------------------- Every day 
Not Relevant 
1  
Somewhat 
Relevant 
2  
Quite Relevant 
3  
Highly Relevant 
4  
4.  Carrying my TPN solution limited what I could do. 
 Not at all -----------------------------------|--------------------------------- Every day 
Not Relevant 
1  
Somewhat 
Relevant 
2  
Quite Relevant 
3  
Highly Relevant 
4  
5. I felt physically strong. 
 Not at all -----------------------------------|--------------------------------- Every day 
Not Relevant 
1  
Somewhat 
Relevant 
2  
Quite Relevant 
3  
Highly Relevant 
4  
6. I was able to participate in the activities I enjoy. 
 Not at all -----------------------------------|--------------------------------- Every day 
Not Relevant 
1  
Somewhat 
Relevant 
2  
Quite Relevant 
3  
Highly Relevant 
4  
7. I was able to walk without difficulty. 
 Not at all -----------------------------------|--------------------------------- Every day 
Not Relevant 
1  
Somewhat 
Relevant 
2  
Quite Relevant 
3  
Highly Relevant 
4  
 
- Please continue to the next page - 
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  During the past 2 weeks, please estimate how often you experienced any of the following situations. 
8. I was able to climb up and down stairs without difficulty. 
 Not at all -----------------------------------|--------------------------------- Every day 
Not Relevant 
1  
Somewhat 
Relevant 
2  
Quite Relevant 
3  
Highly Relevant 
4  
9. I was able to rise from a chair or bed without difficulty. 
 Not at all -----------------------------------|--------------------------------- Every day 
Not Relevant 
1  
Somewhat 
Relevant 
2  
Quite Relevant 
3  
Highly Relevant 
4  
10. I was able to pick up an object from the floor without difficulty. 
 Not at all -----------------------------------|--------------------------------- Every day 
Not Relevant 
1  
Somewhat 
Relevant 
2  
Quite Relevant 
3  
Highly Relevant 
4  
11. I needed to nap when I felt tired. 
 Not at all -----------------------------------|--------------------------------- Every day 
Not Relevant 
1  
Somewhat 
Relevant 
2  
Quite Relevant 
3  
Highly Relevant 
4  
12. I had enough strength and stamina to do daily chores or work. 
 Not at all -----------------------------------|--------------------------------- Every day 
Not Relevant 
1  
Somewhat 
Relevant 
2  
Quite Relevant 
3  
Highly Relevant 
4  
 
- Please continue to the next page - 
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  During the past 2 weeks, please estimate how often you experienced any of the following situations. 
13. The TPN pump disrupted my sleep.  
 Not at all -----------------------------------|--------------------------------- Every day 
Not Relevant 
1  
Somewhat 
Relevant 
2  
Quite Relevant 
3  
Highly Relevant 
4  
14. My sleep was disrupted because I had to get up to move my bowels or empty my ostomy bag. 
 Not at all -----------------------------------|--------------------------------- Every day 
Not Relevant 
1  
Somewhat 
Relevant 
2  
Quite Relevant 
3  
Highly Relevant 
4  
15.  My sleep was disrupted because I had to get up to urinate. 
 Not at all -----------------------------------|--------------------------------- Every day 
Not Relevant 
1  
Somewhat 
Relevant 
2  
Quite Relevant 
3  
Highly Relevant 
4  
16. I ate comfortably in social situations and around others. 
 Not at all -----------------------------------|--------------------------------- Every day 
Not Relevant 
1  
Somewhat 
Relevant 
2  
Quite Relevant 
3  
Highly Relevant 
4  
17. Eating caused me to have gas or feel bloated. 
 Not at all -----------------------------------|--------------------------------- Every day 
Not Relevant 
1  
Somewhat 
Relevant 
2  
Quite Relevant 
3  
Highly Relevant 
4  
    
 - Please continue to the next page - 
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  During the past 2 weeks, please estimate how often you experienced any of the following situations. 
18. Eating caused me to have pain. 
 Not at all -----------------------------------|--------------------------------- Every day 
Not Relevant 
1  
Somewhat 
Relevant 
2  
Quite Relevant 
3  
Highly Relevant 
4  
 
***Answer questions 19-21 if you do NOT have an end-jejunostomy or ileostomy 
but do have bowel in continuity. *** 
 
 
During the past 2 weeks, please estimate how often you experienced any of the 
following situations. 
19. I had episodes of uncontrollable diarrhea. 
 Not at all -----------------------------------|--------------------------------- Every day 
Not Relevant 
1  
Somewhat Relevant 
2  
Quite Relevant 
3  
Highly Relevant 
4  
20. I had to move my bowels shortly after I ate food. 
 Not at all -----------------------------------|--------------------------------- Every day 
Not Relevant 
1  
Somewhat Relevant 
2  
Quite Relevant 
3  
Highly Relevant 
4  
21.  I had to rearrange my daily plans because of how much diarrhea I had. 
 Not at all -----------------------------------|--------------------------------- Every day 
Not Relevant 
1  
Somewhat Relevant 
2  
Quite Relevant 
3  
Highly Relevant 
4  
 
***Answer questions 22-24 if you HAVE an end-jejunostomy or ileostomy. *** 
During the past 2 weeks, please estimate how often you experienced any of the 
following situations. 
22. I had episodes of uncontrollable ostomy leakage. 
 Not at all -----------------------------------|--------------------------------- Every day 
Not Relevant 
1  
Somewhat Relevant 
2  
Quite Relevant 
3  
Highly Relevant 
4  
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  During the past 2 weeks, please estimate how often you experienced any of the following situations. 
23.  I had to empty my ostomy bag shortly after I ate food. 
 Not at all -----------------------------------|--------------------------------- Every day 
Not Relevant 
1  
Somewhat Relevant 
2  
Quite Relevant 
3  
Highly Relevant 
4  
24.  I had to rearrange my daily plans because of how much ostomy output I had. 
 Not at all -----------------------------------|--------------------------------- Every day 
Not Relevant 
1  
Somewhat Relevant 
2  
Quite Relevant 
3  
Highly Relevant 
4  
 - Please continue to the next page for True/False section- 
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 How TRUE or FALSE are the following statements to you? 
1. Good quality of life means being able to do what I want to do when I want to do it. 
 Definitely false ----------------------------|------------------------------- Definitely true 
Not Relevant 
1  
Somewhat Relevant 
2  
Quite Relevant 
3  
Highly Relevant 
4  
2. I eat and enjoy the foods I want to eat. 
 Definitely false ----------------------------|------------------------------- Definitely true 
Not Relevant 
1  
Somewhat Relevant 
2  
Quite Relevant 
3  
Highly Relevant 
4  
3. I am confident in my ability to perform TPN procedures on my own. 
 Definitely false ----------------------------|------------------------------- Definitely true 
Not Relevant 
1  
Somewhat Relevant 
2  
Quite Relevant 
3  
Highly Relevant 
4  
4.  Having one or more nights or days without TPN is important to me. 
 Definitely false ----------------------------|------------------------------- Definitely true 
Not Relevant 
1  
Somewhat Relevant 
2  
Quite Relevant 
3  
Highly Relevant 
4  
5. Having a shorter TPN infusion schedule is important to me. 
 Definitely false ----------------------------|------------------------------- Definitely true 
Not Relevant 
1  
Somewhat Relevant 
2  
Quite Relevant 
3  
Highly Relevant 
4  
6.  I feel relieved knowing my nutritional needs are being met by TPN therapy. 
 Definitely false ----------------------------|------------------------------- Definitely true 
Not Relevant 
1  
Somewhat Relevant 
2  
Quite Relevant 
3  
Highly Relevant 
4  
 - Please continue to the next page - 
 99 
  How TRUE or FALSE are the following statements to you? 
7.  I am fearful of developing complications related to my TPN therapy and/or central line. 
 Definitely false ----------------------------|------------------------------- Definitely true 
Not Relevant 
1  
Somewhat Relevant 
2  
Quite Relevant 
3  
Highly Relevant 
4  
8.  I understand my need for being on TPN therapy. 
 Definitely false ----------------------------|------------------------------- Definitely true 
Not Relevant 
1  
Somewhat Relevant 
2  
Quite Relevant 
3  
Highly Relevant 
4  
9.  I know and have been trained on how to manage my TPN therapy. 
 Definitely false ----------------------------|------------------------------- Definitely true 
Not Relevant 
1  
Somewhat Relevant 
2  
Quite Relevant 
3  
Highly Relevant 
4  
10.  I know and have been trained on how to care for my central line. 
 Definitely false ----------------------------|------------------------------- Definitely true 
Not Relevant 
1  
Somewhat Relevant 
2  
Quite Relevant 
3  
Highly Relevant 
4  
11. I know and have been trained on how to use my pump. 
 Definitely false ----------------------------|------------------------------- Definitely true 
Not Relevant 
1  
Somewhat Relevant 
2  
Quite Relevant 
3  
Highly Relevant 
4  
12. I know and have been trained on the signs and symptoms of a central line infection. 
 Definitely false ----------------------------|------------------------------- Definitely true 
Not Relevant 
1  
Somewhat Relevant 
2  
Quite Relevant 
3  
Highly Relevant 
4  
  - Please continue to the next page - 
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  How TRUE or FALSE are the following statements to you? 
13.  I know and have been trained on the signs and symptoms of dehydration. 
 Definitely false ----------------------------|------------------------------- Definitely true 
Not Relevant 
1  
Somewhat Relevant 
2  
Quite Relevant 
3  
Highly Relevant 
4  
14. I know and have been trained about my diet and what I should be eating. 
 Definitely false ----------------------------|------------------------------- Definitely true 
Not Relevant 
1  
Somewhat Relevant 
2  
Quite Relevant 
3  
Highly Relevant 
4  
15. I know whom to call when I have questions about my TPN therapy. 
 Definitely false ----------------------------|------------------------------- Definitely true 
Not Relevant 
1  
Somewhat Relevant 
2  
Quite Relevant 
3  
Highly Relevant 
4  
16. I feel emotionally supported by my family and friends. 
 Definitely false ----------------------------|------------------------------- Definitely true 
Not Relevant 
1  
Somewhat Relevant 
2  
Quite Relevant 
3  
Highly Relevant 
4  
17. I feel well supported by my home care specialists. 
 Definitely false ----------------------------|------------------------------- Definitely true 
Not Relevant 
1  
Somewhat Relevant 
2  
Quite Relevant 
3  
Highly Relevant 
4  
 
18. I received information about local or national support groups for TPN therapy. 
 Definitely false ----------------------------|------------------------------- Definitely true 
Not Relevant 
1  
Somewhat Relevant 
2  
Quite Relevant 
3  
Highly Relevant 
4  
 - Please continue to the next page -  
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  How TRUE or FALSE are the following statements to you? 
19. I wish I knew more about my TPN therapy. 
 Definitely false ----------------------------|------------------------------- Definitely true 
Not Relevant 
1  
Somewhat Relevant 
2  
Quite Relevant 
3  
Highly Relevant 
4  
 
 
 
 
 
Thank you for completing the  
Home Parenteral Nutrition Patient Reported Outcomes Questionnaire  
Content Validity Index Worksheet 
 
Please SAVE AS a PDF and email to HPNpatientoutcomes@etal.uri.edu 
 
CONTENT VALIDATION OF A HOME PARENTERAL NUTRITION PATIENT 
REPORTED OUTCOMES QUESTIONNAIRE 
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 Appendix F: Phase I Themes and Representative Quotations 
Concerns with tone  
Item Tested Representative Quotations  CRT Decision Implication/Interpretation 
“I am able to live what I 
consider a normal lifestyle.” 
"I think normal is hard to define 
for everybody.  
 
“Normal is relative” 
 
 “I think this question is too 
generalized. each of us has his 
own normal.”  
 
“I don’t like the word normal 
because there’s nothing normal 
with someone on TPN”. 
 
Eliminate Item 
Address concerns with 
the overall tone of the 
item and the patient’s 
most salient concern. 
“I feel like my medical 
condition controls my life” 
"When I say medical condition, 
I don’t think it’s just referring to 
TPN. Mostly (because) I still I 
have other issues." 
 
 “We all have things that come 
up, but I think we are a little 
more hypersensitive”  
 
“…dictates your day to day (not 
controls)". 
Revise Item 
  
“I felt like my health 
limited the things I want 
to do in my life.” 
Increased acceptability of  
the item, tailored to  
patient feedback 
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 “My TPN schedule limits my 
freedom to participate in daily 
activities”. 
 
“…to limit my freedom to me 
makes me think like you can’t. I 
think it’s a more strict of a 
term". 
 
“these are two entirely different 
schedules that you have to focus 
on because TPN schedule might 
be being home making the 
deliveries, getting tools, so that 
schedule is completely different 
than how many hours you’re 
infusing.  
Revise Item 
 
“My daily activities 
were limited by my TPN 
infusion schedule.” Add 
“infusion” to all items 
referring to TPN 
schedule. 
Increased acceptability of 
the item, increased 
clarity, tailored to patient 
feedback  
 
 
 
 
 
Issues with ambiguity and meaning 
“Being on TPN is difficult to 
cope with”. 
“…it’s a lot more difficult than 
to cope…I think if you put 
emotionally there would 
describe it more specifically.” 
 
Revise Item 
 
“Being on TPN was 
difficult to cope with 
emotionally”. 
Increased acceptability of 
the item, increased 
clarity, tailored to patient 
feedback  
“I have to empty my ostomy 
appliance urgently” 
“What do you mean, urgently?” 
 
“…do you mean within five 
minutes...or longer?” 
Eliminate Item 
Addressed unnecessary 
confusion related to 
intended purpose of the 
item, purpose covered in 
other items 
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 “I move my bowels many 
times during the day” and “I 
empty my ostomy appliance 
many times during the 
day/night” 
 
“I would wonder about what 
you mean with “many”?  Many 
to me I don’t think as my 
frequency as many but my 
friend with normal bowels they 
would say like “what... you go 
many times”. 
Eliminate Item 
Addressed unnecessary 
confusion related to 
intended purpose of the 
item, intent covered in 
other items. 
“I am satisfied with the 
amount I sleep at night” 
 
“I think it would be difficult to 
answer just because the fact the 
it varies so much that, someone 
can be satisfied with no sleep so 
it’s very individual” 
Eliminate Item 
Addressed unnecessary 
confusion related to 
intended purpose of the 
item, purpose covered in 
other items 
“I am able to take care of 
myself”. 
 
“That’s ambiguous to me... I am 
able to take care of my hygiene, 
in that sense I am able to take 
care of myself. I can brush my 
teeth…but I can’t live on my 
own. 
Eliminate Item 
Addressed unnecessary 
confusion related to 
intended purpose of the 
item, purpose covered in 
other items 
Concerns with use of jargon or word choice 
“My sleep is disrupted because 
I have to get up to move my 
bowels or change my ostomy 
appliance.” 
“Change is not appropriate in 
here... you don’t change it, you 
empty the bag.” 
Revise Item 
“My sleep was disrupted 
because I had to get up 
to move my bowels or 
empty my ostomy bag” 
Increased acceptability of 
the item. 
“I am fearful of developing 
complications related to my 
“Central line would cover 
everything.” “…most of the 
Revise Item 
“I am fearful of 
Increased acceptability of 
the item. 
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 catheter” and “I am informed 
and well trained about how to 
care for my catheter” 
people say central line and I 
don’t know if everyone knows 
about a catheter” 
 
“if you changed catheter to 
central line would be clear” 
developing 
complications related to 
my central line” and “I 
am informed and well 
trained about how to 
care for my central 
line” 
“I am informed and well-
trained to…” 
“The question here for me is the 
well-trained part…obviously, 
my situation is different but it 
wouldn’t be specifically trained 
doing that, so that’s where I’m 
informed but not trained”  
 
“Well-trained doesn’t seem like 
something I would use, maybe 
knowledgeable?” 
 
 “Informed would be I 
understand why I have TPN, I 
know what it is, what it’s doing 
for me, and I have been taught 
or trained how to manage.” 
Revise Item 
I understand and have 
been trained to….” 
Eliminated unnecessary 
confusion related to 
intended purpose of the 
item. 
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